<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">109197</article-id><article-id pub-id-type="doi">10.7554/eLife.109197</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.109197.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>HEB collaborates with TCR signaling to upregulate <italic>Id3</italic> and enable γδT17 cell maturation in the fetal thymus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Selvaratnam</surname><given-names>Johanna S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>da Rocha</surname><given-names>Juliana DB</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rajan</surname><given-names>Vinothkumar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Helen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Reddy</surname><given-names>Emily C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gams</surname><given-names>Miki S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jenny Jiahuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Murre</surname><given-names>Cornelis</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wiest</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Guidos</surname><given-names>Cynthia J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2538-3178</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Anderson</surname><given-names>Michele Kay</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8820-5910</contrib-id><email>manderso@sri.utoronto.ca</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n0tzs53</institution-id><institution>Biological Sciences, Sunnybrook Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Immunology, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057q4rt57</institution-id><institution>Hospital for Sick Children</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>Department of Molecular Biology, University of California, San Diego</institution></institution-wrap><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0567t7073</institution-id><institution>Blood Cell Development and Function Program, Fox Chase Cancer Center</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sarin</surname><given-names>Apurva</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007wpch15</institution-id><institution>Institute for Stem Cell Science and Regenerative Medicine</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04fhee747</institution-id><institution>National Institute of Immunology</institution></institution-wrap><country>India</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>22</day><month>04</month><year>2026</year></pub-date><volume>14</volume><elocation-id>RP109197</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-09-22"><day>22</day><month>09</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-09-12"><day>12</day><month>09</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.06.08.658490"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-11-12"><day>12</day><month>11</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.109197.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2026-03-12"><day>12</day><month>03</month><year>2026</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.109197.2"/></event></pub-history><permissions><copyright-statement>© 2025, Selvaratnam et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Selvaratnam et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-109197-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-109197-figures-v1.pdf"/><abstract><p>T cells expressing the γδ T cell receptor (TCR) develop in a stepwise process initiating at the αβ/γδ T cell branch point, followed by maturation and acquisition of effector functions, including the ability to produce interleukin-17 (IL-17) as γδT17 cells. Previous studies linked TCR signal strength and fate choices to the transcriptional regulator HEB (<italic>Tcf12</italic>) and its antagonist, Id3, but how these factors regulate different stages of γδ T cell development has not been determined. We found that immature fetal γδTCR<sup>+</sup> cells from conditional <italic>Tcf12</italic> knockout (HEB cKO) mice were defective in activating the γδT17 program at an early stage, whereas <italic>Id3</italic>-deficient (Id3-KO) mice displayed a partial block in γδT17 maturation and a defect in IL-17 production. We also found that HEB cKO mice failed to upregulate <italic>Id3</italic> during γδT17 development, whereas HEB overexpression elevated the levels of <italic>Id3</italic> in collaboration with TCR signaling. Moreover, Egr2 and HEB were bound to several of the same regulatory sites on the <italic>Id3</italic> gene locus in the context of early T cell development. Therefore, our findings reveal an interlinked sequence of events during which HEB and TCR signaling synergize to upregulate <italic>Id3</italic>, which enables maturation and acquisition of the γδT17 effector program.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>gamma delta T cells</kwd><kwd>single-cell RNA sequencing</kwd><kwd>gene networks</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1P01AI102853-06</award-id><principal-award-recipient><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gavpb45</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT153058</award-id><principal-award-recipient><name><surname>Anderson</surname><given-names>Michele Kay</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q9fhm49</institution-id><institution>American Association of Immunologists</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Selvaratnam</surname><given-names>Johanna S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gavpb45</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>FDN154332</award-id><principal-award-recipient><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gavpb45</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT192050</award-id><principal-award-recipient><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gavpb45</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT165973</award-id><principal-award-recipient><name><surname>Guidos</surname><given-names>Cynthia J</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gavpb45</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PPE196061</award-id><principal-award-recipient><name><surname>Anderson</surname><given-names>Michele Kay</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Dynamic regulation of the E-protein/Id axis links TCR signaling to the maturation of IL-17-producing γδ T cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>IL-17-producing γδ T (γδT17) cells are critical effectors in immune responses to bacterial and fungal pathogens and contribute to tissue repair and barrier integrity, particularly at mucosal surfaces (<xref ref-type="bibr" rid="bib80">Ribot et al., 2021</xref>). Beyond host defense, γδT17 cells regulate adipose tissue homeostasis and metabolic function (<xref ref-type="bibr" rid="bib50">Kohlgruber et al., 2018</xref>). However, dysregulation of γδT17 cell function has been linked to autoimmunity and neuroinflammatory disorders, underscoring the importance of precisely controlled γδT17 cell development and function (<xref ref-type="bibr" rid="bib2">Alves de Lima et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Papotto et al., 2018</xref>).</p><p>While significant progress has been made in defining the stages of γδ T cell development, the transcriptional networks that govern lineage commitment and effector fate specification remain incompletely understood. In mice, γδT17 cells arise exclusively during fetal and early neonatal thymocyte development. The earliest wave of γδT17 cells in the fetal thymus, which emerges around embryonic day 17 (E17), originates from T cell precursors expressing the Vγ6 Vδ1 T cell receptor (TCR) (<xref ref-type="bibr" rid="bib32">Haas et al., 1993</xref>; <xref ref-type="bibr" rid="bib87">Shibata et al., 2008</xref>). A second wave of Vγ4 Vδ5 cells, which begins at E18, also gives rise to γδT17 cells (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>; <xref ref-type="bibr" rid="bib82">Sandrock et al., 2018</xref>). By contrast, fetal-restricted Vγ5 Vδ1 γδ T cells are associated with the IFN-γ-producing γδT1 fate (<xref ref-type="bibr" rid="bib38">Havran and Allison, 1990</xref>; <xref ref-type="bibr" rid="bib93">Turchinovich and Hayday, 2011</xref>). Most Vγ1 cells, which appear just before birth and continue to develop in the adult thymus, also differentiate into γδT1 cells (<xref ref-type="bibr" rid="bib14">Buus et al., 2017</xref>). Although Vγ4 cells continue to be generated in the adult thymus, their capacity to give rise to innate γδT17 cells is significantly diminished (<xref ref-type="bibr" rid="bib16">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib82">Sandrock et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Yang et al., 2023</xref>). Instead, adult Vγ4 cells remain poised for peripheral polarization into either γδT17 or γδT1 fates (<xref ref-type="bibr" rid="bib84">Schmolka et al., 2013</xref>). Other subsets, such as IL-4-producing Vγ1 Vδ6.3 cells, emerge primarily in neonatal and young mice (<xref ref-type="bibr" rid="bib31">Grigoriadou et al., 2003</xref>).</p><p>γδ and αβ T cells develop primarily from shared intrathymic T cell progenitors that lack expression of CD4 and CD8 (double negative [DN]) (<xref ref-type="bibr" rid="bib17">Ciofani and Zuniga-Pflucker, 2010</xref>; <xref ref-type="bibr" rid="bib21">Dudley et al., 1995</xref>). These precursors can be further subdivided by CD44 and CD25 expression, with the earliest thymic immigrants classified as CD44<sup>+</sup>CD25<sup>-</sup>, termed early thymic progenitors (ETPs). In the fetal thymus, DN2 (CD44<sup>+</sup>CD25<sup>+</sup>) cells can generate either γδT17 or γδT1 cells, while DN3 (CD44<sup>–</sup>CD25<sup>+</sup>) cells preferentially give rise to γδT1 cells or proceed to αβ development following pre-TCR signaling in a process known as β-selection (<xref ref-type="bibr" rid="bib23">Dutta et al., 2021</xref>). Successful progress through β-selection is followed by upregulation of CD8 and CD4, generating CD4<sup>+</sup>CD8<sup>+</sup> double positive (DP) cells. Commitment to the γδ lineage is initiated by γδTCR signaling, which induces lineage-specifying transcription factors such as Sox13 (<xref ref-type="bibr" rid="bib30">Gray et al., 2013</xref>; <xref ref-type="bibr" rid="bib62">Malhotra et al., 2013</xref>), followed by effector programming factors such as Maf, which are gradually upregulated as differentiation proceeds (<xref ref-type="bibr" rid="bib62">Malhotra et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Pokrovskii et al., 2020</xref>). These factors promote expression of lineage-defining cytokines such as IL-17 and their regulators, including RORγt (<xref ref-type="bibr" rid="bib108">Zuberbuehler et al., 2019</xref>).</p><p>TCR signal strength plays a central role in determining both the γδ T cell lineage choice and γδ T cell effector program (<xref ref-type="bibr" rid="bib54">Lee et al., 2010</xref>; <xref ref-type="bibr" rid="bib101">Zarin et al., 2014</xref>). Weak pre-TCR signals promote αβ lineage progression, whereas intermediate γδTCR signaling favors γδT17 cell development, and stronger signals direct γδT1 differentiation (<xref ref-type="bibr" rid="bib34">Haks et al., 2005</xref>; <xref ref-type="bibr" rid="bib102">Zarin et al., 2015</xref>). Signal strength is modulated by TCR affinity, proximal CD3 signaling, and cytokine crosstalk (<xref ref-type="bibr" rid="bib26">Fahl et al., 2018a</xref>; <xref ref-type="bibr" rid="bib27">Fahl et al., 2018b</xref>; <xref ref-type="bibr" rid="bib63">Michel et al., 2012</xref>; <xref ref-type="bibr" rid="bib69">Muro et al., 2018</xref>). Together, these factors converge on downstream signal transduction pathways, including the ERK-Egr-Id3 axis, which has been identified as a key mediator of TCR signal strength using manipulation of TCR ligands or TCR signaling pathways (<xref ref-type="bibr" rid="bib6">Bain et al., 2001</xref>; <xref ref-type="bibr" rid="bib27">Fahl et al., 2018b</xref>; <xref ref-type="bibr" rid="bib55">Lee et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Munoz-Ruiz et al., 2016</xref>; <xref ref-type="bibr" rid="bib93">Turchinovich and Hayday, 2011</xref>).</p><p><italic>Id3</italic> encodes a dominant-negative helix-loop-helix (HLH) protein that inhibits the expression of E protein-dependent genes. Id3 acts at the post-translational level by binding and sequestering E proteins, including HEB (encoded by <italic>Tcf12</italic>) and E2A (encoded by <italic>Tcf3</italic>), thereby preventing their DNA binding activity. HEB and E2A orchestrate multiple stages of αβ T cell development (<xref ref-type="bibr" rid="bib19">D’Cruz et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">Jones and Zhuang, 2011</xref>; <xref ref-type="bibr" rid="bib46">Jones-Mason et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Leung et al., 2025</xref>). <italic>Id3</italic> expression is proportional to TCR signal strength, suggesting that it may influence T cell fate by titrating E protein activity (<xref ref-type="bibr" rid="bib53">Lauritsen et al., 2009</xref>; <xref ref-type="bibr" rid="bib103">Zarin et al., 2018</xref>). Moreover, <italic>Id3</italic> transcription is directly regulated by graded expression of Egr factors, linking TCR signal strength to E protein target gene expression (<xref ref-type="bibr" rid="bib53">Lauritsen et al., 2009</xref>). We previously showed that HEB-deficient mice exhibit severe defects in γδT17 development, including impaired production of fetal Vγ4 γδ T cells and dysregulated expression of key γδT17 regulators in the Vγ6 subset (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>). HEB directly activates early γδT17 genes, such as <italic>Sox4</italic> and <italic>Sox13</italic>, which are repressed when <italic>Id3</italic> is overexpressed. However, the complete physiological role of HEB in γδ T cell development remains unresolved.</p><p>Here, we investigated the roles of HEB and Id3 in vivo by analyzing fetal γδ T cell development in <italic>Tcf12<sup>fl/fl</sup> Vav-iCre</italic> (HEB conditional knockout [HEB cKO]) and <italic>Id3</italic>-deficient (Id3-KO) mice using flow cytometry and single-cell RNA sequencing (scRNA-seq) of E18 thymocytes. Our results reveal a tiered disruption of γδ T cell development in HEB cKO mice, including dysregulated TRVG and TRDV expression, lineage diversion to the αβ program, and failure to activate key specification factors, including <italic>Id3</italic>. In contrast, γδT17 precursors in Id3-KO mice initiated the γδT17 specification program but failed to mature or produce IL-17. These findings suggest that HEB and Id3 function in an interlinked negative feedback loop that reinforces γδ lineage commitment and mediates the transition from specification to maturation during γδT17 cell development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Strategy for analyzing γδ T cell developmental progression in the fetal thymus</title><p>To analyze γδ T cell development by flow cytometry, we used a panel of antibodies that distinguish developmental stages and lineage fate choices in the mouse fetal thymus. γδ T cells develop from DN2/3 cells in the thymus from precursors with both αβ and γδ T cell potential, with upregulation of CD8 (immature single positive [ISP]) and CD4 marking commitment to the αβ-T cell lineage (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). γδTe (early γδ T cell subsets prior to maturation; CD24<sup>+</sup>) cells arising from DN2/3 cells express γδTCR and CD24 on the cell surface but retain the ability to become either γδ T cells or αβ T cells (dotted arrow) (<xref ref-type="bibr" rid="bib18">Coffey et al., 2014</xref>). Strong γδTCR signaling results in upregulation of CD73 (<italic>Nt5e</italic>) at the γδT1p stage (p=progenitor), followed by downregulation of CD24 (<italic>Cd24a</italic>) to yield mature CD27<sup>+</sup>CD24<sup>-</sup>CD73<sup>+</sup>CD44<sup>-</sup>γδT1 (IFNγ-producing) cells. Signaling through Vγ6 or Vγ4 TCRs results in downregulation of CD24 and upregulation of CD44 as γδ T cell precursors differentiate into immature γδT17p cells, which mature into CD27<sup>-</sup>CD24<sup>-</sup>CD73<sup>-</sup>CD44<sup>+</sup>γδT17 (IL-17-producing) cells (<xref ref-type="bibr" rid="bib92">Sumaria et al., 2017</xref>). CD27 is expressed on all immature γδ T cells and stays on in mature γδT1 cells but is downregulated during γδT17 maturation. Thus, detection of γδTCR, CD4, CD8, CD24, CD73, CD27, and Vγ chains, and the genes that encode them, provides a solid framework for analyzing the impact of gene perturbations on fetal γδ T cell development and maturation.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Partial block in early γδ T cell development and decrease in Vγ4 cells in HEB-deficient mice.</title><p>(<bold>A</bold>) Stages of fetal mouse γδ T cell development. Thymocytes at the DN2 (CD4<sup>-</sup>CD8<sup>-</sup>CD44<sup>+</sup>CD25<sup>+</sup>) and DN3 (CD4<sup>-</sup>CD8<sup>-</sup>CD44<sup>-</sup>CD25<sup>+</sup>) stages of T cell development rearrange and express TCRγ, TCRδ, and TCRβ genes. DN3 cells with productive TCRβ chains expressing a pre-TCR are directed into the αβ-T cell lineage, characterized by upregulation of CD4 and CD8. Cells that express a cell surface γδTCR but have not yet committed to the γδ T cell lineage (γδTe, early γδ T cells) can still be diverted into the αβ T cell lineage (dotted line). γδTCR<sup>+</sup> cells receiving a strong signal become CD73<sup>+</sup>γδT1 cell progenitors (γδT1p) that mature into IFNγ-producing γδT1 cells, whereas cells that receive an intermediate signal become γδT17 cell progenitors (γδT17p) that mature into IL-17-producing γδT17 cells. Downregulation of CD24 and CD27, and upregulation of CD44, marks maturation of γδT17 cells, whereas γδT1 cell maturation is characterized by downregulation of CD24 and maintenance of CD73 and CD27 expression. (<bold>B</bold>) γδ T cell nomenclature. Vγ and Vδ TCR chain genes and proteins can be identified by several different naming systems. Here, we use the Tonegawa nomenclature to refer to the proteins, and the International Immunogenetics Information System (IMGT) for the genes and transcripts. R-Seurat-generated plots use the Mouse Genome Informatics (MGI) nomenclature. The numbering for genes and proteins in these three systems are identical except for the TRDV4 gene, which encodes the Vγ1 protein (highlighted in red). (<bold>C</bold>) Absolute numbers of cells per thymus in wild-type (WT) (blue) and HEB conditional knockout (cKO) (orange) embryonic day 18 (E18) fetal mice. (<bold>D, E</bold>) Percentages of γδ T cells in WT and HEB cKO fetal thymus. (<bold>F</bold>) Absolute number of γδ T cells per thymus in WT and HEB cKO fetal thymus. (<bold>G</bold>) Flow cytometry plots of Vγ4<sup>+</sup> and Vγ1<sup>+</sup> cells within the γδ T cell population in WT and HEB cKO fetal thymus. (H) Flow cytometry plot of Vγ5 and Vγ6 (Vγ1<sup>-</sup>Vγ5<sup>-</sup>) expression on cells within the Vγ1<sup>-</sup>Vγ4<sup>-</sup> population. (I) Percentages of Vγ1<sup>+</sup>, Vγ4<sup>+</sup>, Vγ5<sup>+</sup>, and Vγ6<sup>+</sup> cells out of all γδ T cells in the WT and HEB cKO fetal thymus. (<bold>J</bold>) Absolute numbers of Vγ1<sup>+</sup>, Vγ4<sup>+</sup>, Vγ5<sup>+</sup>, and Vγ6<sup>+</sup> cells per WT and HEB cKO fetal thymus. (<bold>K</bold>) Percentages of immature (CD24<sup>+</sup>) and mature (CD24<sup>-</sup>) γδ T cells out of all γδ T cells in each Vγ subset in WT and HEB cKO fetal thymus. (<bold>L</bold>) Expression of IL-17A protein in γδ T cells from E18 thymus stimulated with PMA/ionomycin as assessed by intracellular staining. Experiments were done two to three times, and results were pooled for analysis. Each biological replicate is depicted as an open circle on the bar graphs. Blue = WT, orange = HEB cKO. Significant differences between WT and HEB cKO subsets were determined using unpaired classic Student’s t-tests. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Defects in αβ T cell development in embryonic day 18 (E18) fetal thymus of HEB conditional knockout (cKO) mice.</title><p>Thymocytes were dissected from E18 wild-type (WT) and HEB cKO littermates and subjected to flow cytometry. At E18, very few cells had become CD4 or CD8 single positive cells, with most cells at the double positive (DP) stage in WT mice. The double negative (DN) to immature single positive (ISP) and ISP to DP transitions were severely compromised in the HEB cKO fetal thymus, in agreement with previous reports of HEB-deficient adult mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig1-figsupp1-v1.tif"/></fig></fig-group><p>It is important to clarify the Vγ and Vδ chain nomenclature used in this study (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Cell surface proteins detected in flow cytometry assays were classified using the Tonegawa nomenclature (<xref ref-type="bibr" rid="bib39">Heilig and Tonegawa, 1986</xref>). When referring to genes or gene transcripts, the International Immunogenetics Information System (IMGT) nomenclature (<xref ref-type="bibr" rid="bib56">Lefranc, 2003</xref>) was used, except in scRNA-seq figures where R-Seurat program output gene names from the Mouse Genome Informatics (MGI) site were preserved (<xref ref-type="bibr" rid="bib7">Baldarelli et al., 2024</xref>). The numbering is the same in all three systems except for Vδ1, which is equivalent to TRDV4 (IMTG) and Trdv4 (MGI).</p></sec><sec id="s2-2"><title>HEB deficiency impairs Vγ4 cell development and inhibits functional maturation of γδT17 cells in the E18 fetal thymus</title><p>To investigate how HEB loss affects fetal γδ T cell development, we crossed <italic>Tcf12<sup>fl/fl</sup></italic> mice with <italic>Tcf12<sup>fl/fl</sup> Vav-iCre</italic> mice to generate littermates without Cre (wild-type [WT]) or with Cre (HEB cKO). HEB cKO mice lack HEB in all hematopoietic cells, as previously described (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>; <xref ref-type="bibr" rid="bib96">Welinder et al., 2011</xref>). At E18, HEB cKO thymocytes showed reduced cellularity (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and a developmental block at the ISP-to-DP transition (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), as previously reported in adult HEB-deficient mice (<xref ref-type="bibr" rid="bib8">Barndt et al., 1999</xref>; <xref ref-type="bibr" rid="bib97">Wojciechowski et al., 2007</xref>). Although γδ T cells were proportionally increased in HEB cKO mice (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>), their absolute numbers were comparable to WT mice (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), indicating that the reduced cellularity was primarily due to the loss of DP thymocytes.</p><p>We next analyzed Vγ chain subsets. Vγ6 cells were identified using an exclusion strategy as cells lacking expression of Vγ1, Vγ4, and Vγ5 (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref>). It should be noted that the flow cytometry plots show the percentage of Vγ5<sup>+</sup> and Vγ5<sup>-</sup> (Vγ6) cells out of the Vγ1<sup>-</sup>Vγ4<sup>-</sup> population (<xref ref-type="fig" rid="fig1">Figure 1H</xref>), whereas the bar graph shows the percentage of Vγ6 cells out of all γδTCR<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). HEB cKO mice exhibited a marked reduction in the frequency (<xref ref-type="fig" rid="fig1">Figure 1G and I</xref>) and absolute numbers (<xref ref-type="fig" rid="fig1">Figure 1J</xref>) of Vγ4<sup>+</sup> cells, and a corresponding increase in the other Vγ subsets (<xref ref-type="fig" rid="fig1">Figure 1G, H, I, and J</xref>). Immature (CD24<sup>+</sup>) cells were more prevalent across all Vγ subsets in HEB cKO mice, except for Vγ4<sup>+</sup> cells, which were primarily CD24<sup>+</sup> and thus had not yet matured, in either WT or HEB cKO mice (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). Furthermore, fetal HEB cKO γδ T cells showed a major impairment in IL-17 production in response to PMA/ionomycin stimulation (<xref ref-type="fig" rid="fig1">Figure 1L</xref>), consistent with our prior fetal thymic organ culture results (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>). These findings indicate that even in the intact E18 thymic environment, HEB is essential for γδT17 cell development.</p></sec><sec id="s2-3"><title>Single-cell transcriptomic analysis reveals a role for HEB in establishing γδ T cell identity</title><p>To assess the transcriptomic impact of HEB deficiency, we performed scRNA-seq on γδTCR<sup>+</sup> thymocytes sorted from E18 WT and HEB cKO littermates. After quality control, we merged the datasets, excluded myeloid cells, and regressed out cell cycle genes using Seurat (<xref ref-type="bibr" rid="bib37">Hao et al., 2021</xref>). Our analysis identified eight distinct clusters (numbered 0–7) visualized as a UMAP (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). WT cells were enriched in clusters 2 and 4, while HEB cKO cells dominated clusters 0, 1, and 3, whereas clusters 5–7 showed a more balanced distribution (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>). To annotate the clusters, we curated 90 γδ T cell subset-defining genes from prior studies (<xref ref-type="bibr" rid="bib43">Inácio et al., 2025</xref>; <xref ref-type="bibr" rid="bib59">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Mistri et al., 2024</xref>; <xref ref-type="bibr" rid="bib71">Narayan et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Pokrovskii et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Spidale et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Yang et al., 2023</xref>; <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The top 10 differentially expressed genes were used to generate a clustered dot plot (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), which we used to identify each cluster. We classified clusters 2 and 6 as early γδT cells (randomly assigned as γδTe1 and γδTe2), clusters 1 and 4 as γδT17 progenitors (γδT17p), cluster 0 as γδT1 progenitors (γδT1p), cluster 7 as mature γδT1 cells (γδT1), cluster 5 as mature γδT17 cells (γδT17), and cluster 3 as αβ lineage-like cells (αβT).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of γδ T cell subsets in wild-type (WT) and HEB conditional knockout (cKO) fetal thymus by single-cell RNA sequencing (scRNA-seq).</title><p>γδ T cells were sorted from embryonic day 18 (E18) fetal thymuses from WT (3) or HEB cKO (3) mice, pooled according to genotype, and subjected to scRNA-seq and analysis. (<bold>A</bold>) Uniform manifold approximation and projection (UMAP) plots depicting merged WT and HEB cKO cells in eight clusters (0–7). (<bold>B</bold>) Grouped UMAP showing the distribution of WT (blue) and HEB cKO (orange) cells across all clusters. (<bold>C</bold>) Split UMAP plots showing the distribution of cells in WT (left) and HEB cKO (right) clusters; note that cluster 4 is restricted to WT cells, and cluster 1 is heavily biased toward HEB cKO cells. (<bold>D</bold>) Genes previously identified as signatures for developmental and functional γδ T cell subsets were compiled from previously published reports. The top 10 most differentially expressed genes from this list were visualized as a clustered dot plot, which was used to assign cluster identities. Two clusters corresponding to early γδ T cells were randomly designated as γδTe1 and γδTe2. (<bold>E</bold>) Numbers of WT (blue) and HEB cKO (orange) cells per cluster. (<bold>F</bold>) Unbiased clustered dot plot of the top 10 most differentially expressed genes across all clusters. In the clustered dot plots, the percentage of cells expressing the gene in each cluster is depicted by the size of the dot, and the color indicates the relative magnitude of expression across clusters.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>References for curated gene list used to identify differentially expressed genes and assign cluster identities in <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig6">6</xref>.</title><p>See spreadsheet.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-109197-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>TRGV and TRDV expression profiling reveals depletion of TRGV4 and TRDV5 transcripts and overexpression of TRDV4 in the HEB conditional knockout (cKO) fetal γδ T cells.</title><p>(<bold>A</bold>) Violin plots of expression of canonical genes that mark γδ T cell subsets. (<bold>B</bold>) Violin plots showing expression of TRGV and TRDV genes in wild-type (WT) versus HEB cKO by cluster. WT = blue, HEB cKO = orange. (<bold>C</bold>) Blended split feature plots showing cells expressing TRGV chains (blue) or TRDV chains (red), and cells co-expressing TRGV and TRDV chains (pink). Co-expression in WT cells is shown on the top panel of each comparison, and HEB cKO cells are shown on the bottom.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Quantification of WT and HEB cKO cells per cluster (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) revealed that the γδT17p clusters segregated by genotype into WT (γδT17pw) and HEB cKO (γδT17pk) cells. HEB cKO cells were also over-represented in the αβT cluster and under-represented in the γδTe1 cluster. An unbiased heatmap of the top 10 most differentially expressed genes across all clusters further validated our assigned identities and revealed additional genes associated with these subsets (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). These findings suggest that the loss of HEB impairs the early γδ T cell program and allows diversion toward the αβ T cell lineage.</p></sec><sec id="s2-4"><title>HEB deficiency suppresses TRDV5 expression and promotes TRDV4 expression</title><p>We next confirmed that WT and HEB cKO cells within each cluster represented equivalent developmental subsets (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). All immature γδ T cell clusters expressed <italic>Cd24a</italic> and <italic>Cd27</italic>, while mature subsets lacked <italic>Cd24a</italic> (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Among mature cells, only γδT1 cells expressed <italic>Cd27</italic> and <italic>Nt5e</italic> (CD73), whereas γδT17 cells were uniquely <italic>Cd44</italic>-positive, consistent with our assignments. We also analyzed TRGV and TRDV gene expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>). In WT cells, TRGV4 and TRDV5 were co-expressed in γδTe and γδT17p populations but were greatly diminished in HEB cKO cells. TRGV6 and TRGV5 transcripts were detectable in γδTe subsets from HEB cKO mice, consistent with a delay in Vγ6 and Vγ5 γδ T cell maturation, whereas TRDV4 was expressed more broadly and at higher levels in all immature HEB cKO γδ T cell subsets relative to WT counterparts. These results indicate that HEB plays an important role in maintaining the subset specificity and magnitude of TRGV5 and TRDV4 expression during γδ T cell development.</p></sec><sec id="s2-5"><title>HEB deficiency impairs early γδ T cell signatures and enhances αβ-T lineage features</title><p>To further define differences between WT and HEB cKO cells at the transcriptomic level, we constructed gene modules composed of suites of signature genes for the γδTe1, γδTe2, αβT, γδT17p, γδT17, γδT1p, and γδT1 subsets, derived from the analysis of merged WT and HEB cKO cells (<xref ref-type="fig" rid="fig2">Figure 2D and F</xref>; see Materials and methods). These modules were used to assign scores in WT (left) and HEB cKO (right) cells, which were visualized using split dot plots.</p><p>This analysis revealed a pronounced loss of the γδTe1 gene signature in HEB cKO cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), alongside a notable increase in the αβT signature (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The γδTe2, γδT17p, and γδT17 gene signatures were also diminished in HEB cKO cells relative to WT, whereas the γδT1p signature was enriched. We also examined the expression of individual genes that were diagnostic for γδ T cell subsets (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) versus committed αβ T cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In the γδTe1 and γδTe2 subsets of HEB cKO mice, <italic>Sox13</italic> and <italic>Etv5</italic> were reduced and <italic>Cd8b1</italic> and <italic>Dgkeos</italic> were elevated relative to their WT counterparts. In γδT17p cells, αβT lineage genes were not detectable, but <italic>Sox13</italic> and <italic>Etv5</italic> were still lower in HEB cKO cells than WT cells, potentially decoupling the specification and commitment events. A less dramatic reduction in <italic>Il1r1</italic> was observed in HEB cKO γδT17 cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), and the levels of <italic>Nrgn</italic> and <italic>Eomes</italic> were similar in γδT1 lineage cells (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). These results indicated that the impact of HEB deficiency at the transcriptomic level was more pronounced in early γδ T cell subsets than in mature γδ T cells.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The αβ T gene program is expanded, and the γδT17 precursor gene program is lost in HEB conditional knockout (cKO) cells.</title><p>γδ T cells sorted from embryonic day 18 (E18) fetal thymuses from wild-type (WT) and HEB cKO mice were subjected to single-cell RNA sequencing (scRNA-seq) and analysis. (<bold>A, B</bold>) Gene modules were generated from subset-biased genes, and cells were scored for each module. Module scores are depicted as split feature plots, with wild-type (WT) plots on the left and HEB cKO plots on the right. Module scores that characterize γδ T cell subsets are shown in (<bold>A</bold>), and a module score for the αβ-T lineage is shown in (<bold>B</bold>). (<bold>C–F</bold>) Split violin plots of genes that typify different γδ T cell subsets as follows: (<bold>C</bold>) γδTe/γδT17p cells, (<bold>D</bold>) αβ T cells, (<bold>E</bold>) γδT17 cells, (<bold>F</bold>) γδT1p and γδT1 cells. Blue = WT, orange = HEB cKO.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig3-v1.tif"/></fig></sec><sec id="s2-6"><title>HEB deficiency obstructs γδT17 progenitor development and dampens TCR signal strength</title><p>The γδT17p subset segregated into distinct clusters in WT and HEB cKO cells, highlighting a critical stage of HEB-dependent regulation. To explore this further, we performed an unbiased differential gene expression analysis in WT cells versus HEB cKO cells and visualized the results using an enhanced volcano plot with stringent thresholds (log<sub>2</sub>FC&gt;0.5, –log<sub>10</sub>p&gt;25) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Many of the top differentially expressed genes were signature markers of γδT17 differentiation, including <italic>Blk, Sox13</italic>, and <italic>Etv5</italic>, all of which were downregulated in HEB cKO cells. <italic>Trdv4</italic> was among the most upregulated genes in HEB cKO γδT17p cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Decreases in T cell effector differentiation and T cell receptor (TCR) signaling genes in γδT17p cells from HEB conditional knockout (cKO) mice.</title><p>(<bold>A</bold>) Volcano plots showing differential gene expression in γδT17p cells from wild-type (WT) versus HEB cKO fetal thymus. Genes expressed at higher levels in HEB cKO cells are on the left, and genes expressed at lower levels in HEB cKO cells are on the right. Significance (pink) was set at log<sub>2</sub>FC&gt;0.5 and –log<sub>10</sub>p&lt;10<sup>25</sup>. (<bold>B</bold>) Gene ontology analysis of genes significantly reduced in HEB cKO γδT17p cells relative to WT, with significance set at avg log<sub>2</sub>FC&gt;0.25 and adjusted p-value&lt;0.001. Bar plots show pathway enrichment (fold enrichment) and significance by false discovery rate (FDR) for each functional category defined in the Kyoto Encyclopedia of Genes and Genomics (KEGG) pathway list. Minimum genes for pathway inclusion was set at 5, and FDR cutoff was set at 0.05. (<bold>C</bold>) Relative expression of genes associated with strong TCR signaling in WT and HEB cKO cells in each cluster. (<bold>D</bold>) Relative expression of <italic>Id3</italic> in immature γδ T cell subsets from WT and HEB cKO mice. (<bold>E</bold>) Split feature plots showing expression of <italic>Id3</italic> across all clusters in WT versus HEB cKO cells. (<bold>F</bold>) Relative expression of <italic>Maf</italic> and <italic>Rorc</italic> in WT versus HEB cKO γδT cell subsets. WT = blue, HEB cKO = orange.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Differentially expressed genes between wild-type (WT) and HEB conditional knockout (cKO) γδT17 precursor populations from <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title><p>See spreadsheet.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-109197-fig4-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Enriched Kyoto Encyclopedia of Genes and Genomics (KEGG) pathways and gene members between wild-type (WT) and HEB conditional knockout (cKO) γδT17 precursor populations, as shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title><p>See spreadsheet.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-109197-fig4-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Patterns of E protein and Id protein gene expression during γδ T cell development in wild-type (WT) and HEB conditional knockout (cKO) mice.</title><p>(<bold>A</bold>) Relative expression of <italic>Tcf12</italic> (HEB), <italic>Tcf3</italic> (E2A), <italic>Id3</italic>, and <italic>Id2</italic> in WT versus HEB cKO cells by cluster. WT = blue, HEB cKO = orange. (<bold>B–F</bold>) Co-expression of E protein and Id protein transcripts assessed by blended split feature plots, for (<bold>B</bold>) <italic>Tcf12</italic> and <italic>Tcf3</italic>, (<bold>C</bold>) <italic>Tcf12</italic> and <italic>Id3</italic>, (<bold>D</bold>) <italic>Tcf3</italic> and <italic>Id3</italic>, (<bold>E</bold>) <italic>Tcf12</italic> and <italic>Id2</italic>, and (<bold>F</bold>) <italic>Tcf3</italic> and <italic>Id2</italic>. Pink = co-expression.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig4-figsupp1-v1.tif"/></fig></fig-group><p>We next generated a list of differentially expressed genes between WT and HEB cKO γδT17p cells using less stringent criteria (adj p-value&gt;0.001, log<sub>2</sub>FC &gt;0.25) (<xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). This list was subjected to gene ontology analysis using ShinyGO, which resulted in a list of Kyoto Encyclopedia of Genes and Genomics (KEGG) pathways with reduced gene representation in HEB cKO γδT17p cells. We observed significant depletion of gene pathways related to TCR signaling (PD-1 checkpoint, NF-κB signaling) and Th1, Th2, and Th17 differentiation in HEB cKO cells relative to WT cells (<xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>). Three key markers of TCR signal strength, <italic>Cd5</italic>, <italic>Cd69</italic>, and <italic>Egr1</italic>, were reduced in both γδTe2 and γδT17p subsets in HEB cKO mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). <italic>Id3</italic> expression was markedly decreased in HEB cKO γδTe cells and nearly absent in γδT17p cells but remained intact in γδT1p and γδT1 cells (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). We also examined the expression of <italic>Maf</italic> and <italic>Rorc</italic>, two key regulators of γδT17 maturation, and found that they were expressed similarly between HEB cKO and WT cells in each cluster (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Therefore, HEB modulates TCR signaling during γδT17 specification but appears to be largely dispensable for the expression of γδT17 cell maturation factors.</p></sec><sec id="s2-7"><title><italic>Id3</italic> expression in γδT17 progenitors is controlled through HEB-dependent mechanisms</title><p>To further elucidate the landscape of E protein and Id protein expression during γδ T cell development, we examined the expression of <italic>Tcf12</italic> (encodes HEB), <italic>Tcf3</italic> (encodes E2A), <italic>Id3</italic>, and <italic>Id2</italic> in each cluster (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). <italic>Id1</italic> and <italic>Id4</italic> transcripts were not detectable in any of our datasets. It should be noted that the <italic>Tcf12</italic> deletion occurs in one of the last exons of a 200 kb gene locus, and although the protein is absent (<xref ref-type="bibr" rid="bib8">Barndt et al., 1999</xref>), some mRNA expression can still be detected. In WT mice, γδTe cells co-expressed <italic>Tcf12</italic>, <italic>Tcf3</italic>, and <italic>Id3</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C, E</xref>), consistent with dynamic regulation of E protein-dependent target gene expression during the αβ/γδ fate choice (<xref ref-type="bibr" rid="bib70">Murre, 2019</xref>). γδT17p cells co-expressed <italic>Tcf12</italic> and <italic>Tcf3</italic>, whereas γδT1 cells co-expressed <italic>Tcf3</italic> and <italic>Id3</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B and D</xref>). <italic>Id2</italic> expression was restricted to mature γδT17 and mature γδT1 cells in both WT and HEB cKO mice. <italic>Tcf3</italic> expression was also unaffected by a lack of HEB, indicating that <italic>Tcf3</italic> and <italic>Id2</italic> expression are HEB-independent in this context (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E and F</xref>). <italic>Id3</italic> expression was disrupted in HEB cKO cells in γδTe and γδT17 cells but not in γδT1p cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and D</xref>). This analysis reveals that <italic>Id3</italic> expression was disrupted only in cells that normally express <italic>Tcf12</italic>.</p></sec><sec id="s2-8"><title>Loss of <italic>Id3</italic> impairs CD73 upregulation and γδT17 cell function in the fetal thymus</title><p>Given the clear dependence of <italic>Id3</italic> expression on HEB in specific γδ T cell subsets, we next investigated how loss of <italic>Id3</italic> itself affects γδ T cell development using E18 fetal thymocytes from <italic>Id3</italic> knockout (Id3-KO) mice. Total thymic cellularity in Id3-KO mice was comparable to WT controls (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), but the proportion of γδ T cells among total thymocytes was reduced (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). Analysis of Vγ chain usage revealed no major differences between WT and Id3-KO mice, although there was a slight increase in the proportion of Vγ6 cells in Id3-KO γδ T cells (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). Interestingly, very few Id3-KO γδ T cells expressed CD73 (encoded by <italic>Nt5e</italic>) (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>), including Vγ5 and Vγ1 cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). <italic>Nt5e</italic> expression is upregulated in response to strong TCR signaling during γδ T cell development, and it can also be induced in response to short-term stimulation (<xref ref-type="bibr" rid="bib13">Buus et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Coffey et al., 2014</xref>). To determine whether the deficiency in CD73 expression in Id3-KO mice reflected an expansion of CD73<sup>-</sup> cells or a failure to induce <italic>Nt5e</italic>, we cultured E18 fetal thymocytes from WT and Id3-KO mice with PMA/ionomycin (P/I) for 4 hr and measured CD73 expression in γδ T cells by flow cytometry (<xref ref-type="fig" rid="fig5">Figure 5I and J</xref>). While CD73 was robustly induced in a substantial fraction of CD27<sup>+</sup> γδ T cells from WT mice, it remained nearly undetectable in Id3-KO γδ T cells, indicating a direct role for Id3 in the regulation of <italic>Nt5e</italic> expression.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Fetal γδ T cells from Id3-KO mice are defective in CD73 upregulation and interleukin-17 (IL-17) production.</title><p>(<bold>A</bold>) Absolute numbers of cells per embryonic day 18 (E18) fetal thymus from wild-type (WT) and Id3-KO littermate mice. (<bold>B, C</bold>) Quantification (<bold>B</bold>) and flow cytometry plots (<bold>C</bold>) of the percentages of γδ T cells out of all thymocytes. (<bold>D, E</bold>) Flow cytometry plots (<bold>D</bold>) and quantification (<bold>E</bold>) of Vγ1<sup>+</sup> and Vγ4<sup>+</sup> out of all γδ T cells. (<bold>F</bold>) Percentages of Vγ5<sup>+</sup> and Vγ6<sup>+</sup> out of all γδ T cells. (<bold>G</bold>) Flow cytometry plots of CD24 and CD73 expression in γδTCR<sup>+</sup> cells. (<bold>H</bold>) Quantification of mature (CD24<sup>-</sup>) CD73<sup>+</sup> and CD73<sup>-</sup> γδ T cells out of all γδ T cells. (<bold>I</bold>) Flow cytometry plots of expression of CD27 and CD73 expression in unstimulated (top) and stimulated (bottom) γδ T cells. (<bold>J</bold>) Percentages of CD27<sup>+</sup>CD73<sup>+</sup> cells out of all γδ T cells under unstimulated or stimulated conditions. (K, L) Flow cytometry (<bold>K</bold>) and quantification (<bold>L</bold>) of the percentages of CD27<sup>-</sup>CD73<sup>-</sup>CD24<sup>-</sup> (primarily mature Vγ6) cells expressing IL-17 in response to stimulation. Experiments were done two to three times, and results were pooled for analysis. Each biological replicate is depicted as an open circle on the bar graphs. Blue = WT, pink = Id3 KO. P/I=phorbol 12-myristate 13-acetate (PMA)+ionomycin. Significant differences between WT and Id3-KO subsets were determined using unpaired classic Student’s t-tests. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>CD73 is upregulated during development of Vγ5 and Vγ1 γδ T cells in wild-type (WT) but not Id3-KO fetal thymus.</title><p>Flow cytometry plots of CD24 and CD73 expression within the Vγ subsets from WT and Id3-KO embryonic day 18 (E18) fetal thymus.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Mature CD73<sup>-</sup> γδ T cells typically exhibit a bias toward the γδT17 lineage (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>). We hypothesized that loss of <italic>Id3</italic> might re-direct γδT1-fated cells into the γδT17 lineage. However, upon stimulation, Id3-KO γδ T cells failed to produce IL-17 (<xref ref-type="fig" rid="fig5">Figure 5K and L</xref>), indicating that Id3 deficiency does not promote γδT17 differentiation. These findings highlight a critical role for <italic>Id3</italic> in the functional maturation of both CD73<sup>+</sup> and CD73<sup>-</sup> γδ T cells.</p></sec><sec id="s2-9"><title>Loss of Id3 disrupts expression of γδT17 cell maturation transcription factors</title><p>To further investigate how Id3 deficiency affects γδ T cell development, we measured intracellular expression of PLZF (encoded by <italic>Zbtb16</italic>) and MAF in E18 γδ T cells from WT and Id3-KO mice by flow cytometry (<xref ref-type="fig" rid="fig6">Figure 6</xref>). PLZF is expressed in innate fetal/neonatal γδ T cells and adult iNKT and IL-4-producing γδ T cells (<xref ref-type="bibr" rid="bib1">Alonzo et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Kreslavsky et al., 2009</xref>; <xref ref-type="bibr" rid="bib61">Lu et al., 2015</xref>). To compare developmental stages within Vγ subsets between WT and Id3-KO γδ T cells, we gated on: (1) immature (CD24<sup>+</sup>) Vγ4 cells, which comprised the majority of Vγ4 cells, (2) immature (CD24<sup>+</sup>) Vγ6 cells, and (3) mature (CD24<sup>-</sup>) Vγ6 cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This analysis yielded three populations, based on PLZF and MAF expression: PLZF<sup>+</sup>MAF<sup>+</sup>, PLZF<sup>+</sup>MAF<sup>–</sup>, and PLZF<sup>–</sup>MAF<sup>–</sup> cells (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Intact γδ T commitment gene program and impaired γδT17 maturation program in Id3-KO mice.</title><p>(<bold>A</bold>) Flow cytometry plots showing the percentages of cells expressing PLZF and/or MAF in immature (CD24<sup>+</sup>) Vγ4 and Vγ6 cells, and in mature (CD24<sup>-</sup>) Vγ6 cells (note that mature Vγ4 cells are not present in the embryonic day 18 [E18] fetal thymus). (<bold>B</bold>) Quantification of the percentages of cells expressing PLZF and MAF (top), PLZF only (middle), or neither (bottom) within the immature Vγ4 and Vγ6 subsets, and the mature Vγ6 subset. (<bold>C</bold>) Mean fluorescent intensities of PLZF in the PLZF<sup>+</sup>MAF<sup>+</sup> and PLZF<sup>+</sup>MAF<sup>-</sup> populations within the immature and mature Vγ subsets. (<bold>D, E</bold>) scRNA-seq UMAP plots of γδ T cells as merged (<bold>D</bold>) or split (<bold>E</bold>) into wild-type (WT) versus Id3-KO populations. (F) Number of WT and Id3-KO cells per cluster. (<bold>G</bold>) Clustered dot plot of curated gene sets used to assign γδT17p, γδTe, γδT17, and γδT1 identities. (<bold>H</bold>) Expression of γδ T cell commitment genes in WT versus Id3-KO cells by cluster. (<bold>I</bold>) Expression of γδT17 maturation genes in WT versus Id3-KO cells by cluster. Experiments were done two to three times, and results were pooled for analysis. Each biological replicate is depicted as an open circle on the bar graphs. Blue = WT, pink = Id3 KO. Significant differences between WT and Id3-KO subsets were determined using unpaired classic Student’s t-tests. **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Identification of γδ T cell subsets from embryonic day 18 (E18) wild-type (WT) and Id3-KO double negative (DN) cells using single-cell RNA sequencing (scRNA-seq).</title><p>WT and Id3-KO E18 thymocytes were pooled and subjected to magnetic sorting to obtain CD4<sup>-</sup>CD8<sup>-</sup> (DN) cells for scRNA-seq. (<bold>A</bold>) Uniform manifold approximation and projection (UMAP) of merged dataset depicting 11 clusters (0–10). (<bold>B</bold>) Expression of lineage-defining genes to assign identities to clusters in merged dataset: <italic>Cd3e</italic> for T lineage, <italic>Sox13</italic> for γδT lineage, <italic>Maf</italic> for myeloid, and γδT17 lineages, and <italic>Il2rb</italic> and <italic>Xcl1</italic> for γδT1 lineage, and <italic>Spi1</italic> (encodes PU.1) for myeloid lineage. (<bold>C</bold>) Expression of genes defining DN subsets: <italic>Cpa3</italic> for DN2 and γδ T cells, <italic>Il2ra</italic> (encodes CD25) for DN2/3 cells, <italic>Ptcra</italic> (encodes pre-Ta) for DN3 cells, and <italic>Id3</italic> for γδ T cells and DN4 cells. <italic>Cd8b1</italic> is upregulated transcriptionally before surface expression and marks αβ-T lineage commitment within DN4 cells. <italic>Cd4</italic> was undetectable, validating our MACS enrichment strategy. (<bold>D</bold>) Expression of <italic>Rorc</italic> in WT versus Id3-KO cells in γδ T cell subsets. (E) <italic>Rorc</italic> expression in all WT and Id3-KO clusters.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>γδTCR<sup>+</sup> cells from embryonic day 18 (E18) Id3-KO mice include a population of CD4<sup>+</sup>CD8<sup>+</sup> cells, indicating diversion to the αβ-T lineage program.</title><p>E18 fetal thymocytes were subjected to flow cytometry. Cells were gated on the TCRγδ<sup>+</sup>CD3<sup>+</sup> population and analyzed for expression of CD4 and CD8 which was quantified in a bar graph depicting the percentage of CD4<sup>+</sup>CD8<sup>+</sup> (DP) cells within the γδTCR<sup>+</sup> population. Experiments were done two to three times, and results were pooled for analysis. Each biological replicate is depicted as an open circle on the bar graphs. Significance between WT and Id3-KO subsets was determined using unpaired classic Student’s t-tests. ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig6-figsupp2-v1.tif"/></fig></fig-group><p>In WT mice, most immature Vγ4 and Vγ6 cells expressed PLZF, with about half of the PLZF<sup>+</sup> cells co-expressing MAF. Nearly all mature Vγ6 cells co-expressed PLZF and MAF. Immature Vγ4 and Vγ6 subsets in Id3-KO mice had reduced proportions of PLZF<sup>+</sup>MAF<sup>+</sup> cells and increased percentages of PLZF<sup>-</sup>MAF<sup>-</sup> cells relative to WT. Mature Vγ6 cells in Id3-KO mice exhibited a more severe disruption, with only ~50% co-expressing PLZF and MAF, and significant increases within the PLZF<sup>+</sup>MAF<sup>-</sup> or PLZF<sup>-</sup>MAF<sup>-</sup> subsets. Moreover, mean fluorescence intensity analysis revealed substantially lower PLZF protein levels in Id3-KO cells across all subsets, especially immature cells, suggesting that this defect is not solely due to delayed maturation (<xref ref-type="fig" rid="fig6">Figure 6C</xref>).</p></sec><sec id="s2-10"><title>Id3 deficiency promotes the αβ-T lineage but does not disrupt the expression of early γδ T cell regulators</title><p>To investigate population dynamics and gene expression changes in Id3-KO fetal thymocytes, we performed scRNA-seq on CD4<sup>-</sup>CD8<sup>-</sup> E18 fetal thymocytes. This strategy was designed to capture γδ T-biased cells with low surface γδTCR that might be missed by flow cytometric cell sorting. After quality control, WT and Id3-KO datasets were merged and subjected to dimensionality reduction, which identified 11 clusters (0–10) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Violin plots of lineage and subset-specific genes identified two γδ T cell clusters (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), which were computationally isolated and re-clustered. This process yielded four new γδ T cell clusters (0–3), which we identified as γδTe, γδT17p, γδT17, and γδT1 cells (<xref ref-type="fig" rid="fig6">Figure 6D and E</xref>), using the same strategy shown in <xref ref-type="fig" rid="fig2">Figure 2</xref> (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). This scRNA-seq dataset lacked a γδ/αβ T lineage cluster, likely due to low cell numbers and/or exclusion of CD4<sup>+</sup> and CD8<sup>+</sup> cells in the enrichment strategy. However, flow cytometry of E18 fetal thymocytes revealed a significantly higher proportion of TCRγδ<sup>+</sup> cells co-expressing CD4 and CD8 in Id3-KO mice than in WT mice, indicating a bias toward the αβ T cell program (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). Notably, our scRNA-seq analysis showed that γδ T cell specification genes (<italic>Sox13</italic>, <italic>Etv5</italic>) and <italic>Tcf12</italic> were unaffected by the decrease in <italic>Id3</italic> (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). These results decouple the loss of <italic>Id3</italic> from the disruption of early γδ T cell regulators in HEB cKO mice.</p></sec><sec id="s2-11"><title><italic>Id3</italic> is required for the induction of γδT17 regulators at the transcriptional level</title><p>Compared to WT, the Id3-KO mice had increased numbers of γδT17p cells and fewer mature γδT17 cells (<xref ref-type="fig" rid="fig6">Figure 6F</xref>), consistent with a partial block in γδT17 maturation. <italic>Id2</italic> expression was markedly increased in all Id3-KO γδ T cell subsets (<xref ref-type="fig" rid="fig6">Figure 6I</xref>), consistent with a previously reported compensatory role (<xref ref-type="bibr" rid="bib104">Zhang et al., 2014</xref>). <italic>Maf</italic> and <italic>Zbtb16</italic> transcripts were markedly reduced in Id3-KO cells at the γδTe stage but recovered to near WT levels in mature γδT17 cells (<xref ref-type="fig" rid="fig6">Figure 6I</xref>). We noted a similar impact on expression of <italic>Rora</italic> in Id3-KO mice. <italic>Rora</italic> is not required for γδT17 cell function (<xref ref-type="bibr" rid="bib10">Barros-Martins et al., 2016</xref>), but does play roles in the development of Th17 (<xref ref-type="bibr" rid="bib35">Hall et al., 2022</xref>) and ILC3 cells (<xref ref-type="bibr" rid="bib60">Lo et al., 2016</xref>). We also examined expression of <italic>Rorc</italic> (encodes RORγt) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Given the decrease in other genes involved in γδT17 cell maturation and the dependence of <italic>Rorc</italic> expression on MAF in γδT17 cells (<xref ref-type="bibr" rid="bib108">Zuberbuehler et al., 2019</xref>), we were surprised to find that <italic>Rorc</italic> was higher in Id3-KO γδT17p cells than in WT γδT17p cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>) and was also elevated in the <italic>Cd8a</italic>-expressing DN4 subset (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Although RORγt is a critical regulator of γδT17 development and function, it is also upregulated after β-selection and maintains DP cell survival (<xref ref-type="bibr" rid="bib98">Xi et al., 2006</xref>), suggesting that the increase we observed in the γδT17p cells could in part be due to αβ-T cell lineage diversion.</p></sec><sec id="s2-12"><title>ChIP-seq analysis reveals shared HEB, E2A, and Egr2 binding sites in the <italic>Id3</italic> locus</title><p>Although our data showed that HEB is necessary for <italic>Id3</italic> expression during γδT17 development, it remained unclear whether HEB directly regulates <italic>Id3</italic>. The <italic>Id3</italic> gene locus is composed of three exons adjacent to the long non-coding RNA gene <italic>Gm42329</italic>, which lies in the opposite orientation (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). To assess direct binding of HEB and/or E2A to the <italic>Id3</italic> locus, we analyzed ChIP-seq datasets from <italic>Rag2</italic><sup>-/-</sup> DN3 thymocytes (<xref ref-type="bibr" rid="bib28">Fahl et al., 2021</xref>). This analysis identified three major binding regions for both HEB and E2A upstream of the first exon of <italic>Id3</italic>, each containing multiple peaks. We also examined ChIP-seq datasets from DN3 cells stimulated with anti-CD3 or anti-TCRβ to mimic TCR signaling (<xref ref-type="bibr" rid="bib77">Pekowska et al., 2011</xref>; <xref ref-type="bibr" rid="bib86">Seiler et al., 2012</xref>). RNA polymerase II bound the <italic>Id3</italic> promoter in <italic>Rag2<sup>-/-</sup></italic> mice stimulated with anti-CD3ε, revealing active <italic>Id3</italic> transcription in cells that had experienced CD3-mediated signaling. Additionally, we observed binding of Egr2 to two sites that overlapped with the HEB/E2A bound regions in total thymocytes from mice that had been injected with anti-TCRβ (<xref ref-type="bibr" rid="bib86">Seiler et al., 2012</xref>). Notably, H3K27me3 repressive marks were detectable across the <italic>Gm42329</italic> locus but were absent from <italic>Id3</italic>, indicating that <italic>Id3</italic> is epigenetically poised for activation before pre-TCR and/or γδTCR signaling occurs.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Synergistic upregulation of <italic>Id3</italic> by HEB and CD3 signaling.</title><p>(<bold>A</bold>) ChIP-seq data analysis of the binding of HEB, E2A, RNA polymerase, and Egr2, and the extent of H3K27me3 chromatin modification, in DN3 and/or DN4 cells at the <italic>Id3</italic> gene locus, obtained from publicly available datasets (see Materials and methods for accession numbers). The cell type and antibody used in each experiment are indicated to the right of the tracks. Peaks bound by HEB, E2A, and/or Egr2 are indicated in boxes. Inset shows the <italic>Id3</italic> exons and the adjacent <italic>Gm42329</italic> long non-coding RNA. (<bold>B</bold>) Diagram of experimental design. SCID.adh cells transduced with HEBAlt or control retroviral vectors were cultured for 16 hr in the presence or absence of the anti-TAC antibody, which induces signaling through the CD3 complex. (<bold>C, E</bold>) Flow cytometry plots (<bold>C</bold>) and quantification (<bold>E</bold>) of CD25 upregulation with and without stimulation and/or HEB expression. (D) <italic>Id3</italic> mRNA expression relative to β-actin as determined by quantitative RT-PCR. Rag = <italic>Rag2<sup>-/-</sup></italic> mouse thymocytes, which are arrested at the DN3 stage of development. Experiments were done two times, and results were pooled for analysis. Each biological replicate is depicted as an open circle on the bar graphs. Significant differences were determined using unpaired classic Student’s t-tests. **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Accessibility and occupancy of Id3 locus elements by HEB, E2A, and Egr2 before and after pre-T cell receptor (TCR) or γδTCR signaling.</title><p>(<bold>A</bold>) <italic>Rag2<sup>-/-</sup></italic> DN3 cells were transduced with the KN6 γδTCR (DN3 + γδTCR) or not (DN3) and stimulated with γδTCR ligand, followed by ChIP-seq analysis of HEB (green) and E2A (blue) binding. Peaks in the <italic>Id3</italic> locus were aligned to Egr2 ChIP data to locate overlapping sites of binding. These peaks were also aligned to context-specific accessibility peaks obtained from ATAC-seq analysis of <italic>Rag2<sup>-/-</sup></italic> DN3 (pre-selection) cells, and DN3 and DN4 (post-selection) cells from wild-type (WT) and HEB conditional knockout (cKO) mice. Representative traces from one of two replicates are shown. Sites showing overlapping HEB/E2A/Egr2 peaks and decreased accessibility in HEB cKO samples are designated as <italic>HE1</italic> and <italic>HE2</italic>. Circled peaks indicate a lower degree of accessibility in HEB cKO mice. (<bold>B</bold>) Transcription factor binding motifs for HEB/E2A (E box; blue) and Egr2 (Egr; red) were identified in <italic>HE1</italic> and <italic>HE2</italic> in close proximity to each other. Colors of sequence bars indicate intensity of ChIP-seq signal, as shown in (<bold>A</bold>). It should be noted that HEB/E2A binding, but not Egr2 binding, is dampened in post-selection cells, as expected due to the increase in Id3 expression. Ranges of ATAC-seq traces were kept constant to allow direct comparisons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Model for HEB and Id3 requirements in the development and maturation of γδT17 cells.</title><p>(<bold>A</bold>) Strong γδTCR signaling induces high levels of Egr2, which are sufficient to drive <italic>Id3</italic> upregulation without HEB, whereas HEB is also required under lower γδTCR signaling conditions. Distinct cytokine signals also participate in <italic>Id3</italic> modulation and γδ T cell lineage choice. (<bold>B</bold>) γδT17 development occurs in two stages, the first of which is HEB-dependent, and the second of which is Id3-dependent. HEB induces <italic>Id3</italic> during the first stage, which acts in a negative feedback loop to inhibit HEB activity during the second stage. The absence of <italic>Id3</italic> allows higher E protein activity, which inhibits second stage regulators but also results in <italic>Id2</italic> upregulation, providing partial compensation for the loss of <italic>Id3</italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-109197-fig7-figsupp2-v1.tif"/></fig></fig-group><p>Given that the data from the Egr2 and HEB/E2A ChIP-seq analyses were generated using different thymocyte subsets, we analyzed additional ChIP-seq data for HEB and E2A binding in <italic>Rag2<sup>-/-</sup></italic> DN3 cells that had been transduced with retroviral constructs encoding the KN6γδTCR and cultured with stroma expressing the weak KN6 ligand T10 for 4 days (<xref ref-type="bibr" rid="bib28">Fahl et al., 2021</xref>). These <italic>Rag2<sup>-/-</sup></italic> DN3 + γδTCR cells allowed us to examine HEB/E2A binding to sites in the <italic>Id3</italic> locus in a cellular context more closely aligned to the Egr2 binding assay (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). This analysis revealed that the binding of HEB/E2A on those sites persisted after weak γδTCR signaling, strengthening the likelihood that concurrent binding of HEB/E2A and Egr2 occurs during this developmental transition. We noted that HEB/E2A binding was slightly dampened in <italic>Rag2<sup>-/-</sup></italic> DN3 + γδTCR cells relative to <italic>Rag2<sup>-/-</sup></italic> DN3 cells, consistent with the induction of <italic>Id3</italic> and subsequent Id3-mediated disruption of E protein binding.</p><p>We designated the regions of overlapping HEB, E2A, and Egr2 binding as <italic>Tcf12<sup>HE1</sup></italic> and <italic>Tcf12<sup>HE2</sup></italic>. Sequence-level analysis of <italic>Tcf12<sup>HE1</sup></italic> and <italic>Tcf12<sup>HE2</sup></italic> allowed the identification of predicted E protein binding sites (E box) in close proximity to Egr binding sites (Egr) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>), suggesting that HEB/E2A and Egr2 may participate in a gene regulatory protein complex. Together, these findings support the hypothesis that HEB and E2A work in concert with Egr2 to modulate <italic>Id3</italic> transcription in thymocytes undergoing TCR-mediated selection.</p><p>To examine how the chromatin landscape of the <italic>Id3</italic> locus might change across this transition, we generated ATAC-seq data from DN3 and DN4 cells, as well as <italic>Rag2</italic><sup>-/-</sup> DN3 cells, to provide a genuine pre-selection context (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Alignment of ATAC-seq and ChIP-seq peaks in the <italic>Id3</italic> locus revealed accessibility of <italic>Tcf12<sup>HE1</sup></italic> and <italic>Tcf12<sup>HE2</sup></italic> in <italic>Rag2<sup>-</sup></italic><sup>/-</sup>, WT DN3, and WT DN4 cells, strengthening their relevance. Given the known ability of E2A and HEB to induce chromatin remodeling (<xref ref-type="bibr" rid="bib24">Emmanuel et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Lin et al., 2010</xref>), we also examined accessibility in DN3 and DN4 cells from HEB cKO mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Alignment of ATAC-seq and ChIP-seq peaks in the <italic>Id3</italic> locus revealed accessibility of <italic>Tcf12<sup>HE1</sup></italic> and <italic>Tcf12<sup>HE2</sup></italic> in <italic>Rag2</italic><sup>-/-</sup> DN3, WT DN3, and WT DN4 cells. However, accessibility of <italic>Tcf12<sup>HE1</sup></italic> and <italic>Tcf12<sup>HE2</sup></italic> was dampened in HEB cKO cells, especially at the DN3 stage, suggesting that HEB may be involved in remodeling the <italic>Id3</italic> locus, resulting in a poised state that enables TCR-dependent transcription factors like Egr2 to induce <italic>Id3</italic> proportionally to TCR signal strength.</p></sec><sec id="s2-13"><title>TCR signaling and HEB converge to potentiate <italic>Id3</italic> transcription</title><p>To test whether HEB can cooperate with TCR/CD3 signaling to upregulate <italic>Id3</italic>, we used a gain-of-function approach. We took advantage of the SCID.adh cell line, which expresses a chimeric hIL-2Rα:CD3ε receptor that mimics pre-TCR signaling when stimulated with anti-TAC (hIL-2Rα) antibody (<xref ref-type="bibr" rid="bib15">Carleton et al., 1999</xref>). Stimulation results in downregulation of CD25, <italic>Rag1</italic>, <italic>Rag2</italic>, and <italic>Ptcra</italic>, while inducing <italic>Trac</italic> germline transcripts, recapitulating pre-TCR activity. We transduced SCID.adh cells with either control or HEB-expressing retroviruses to generate control and HEB-overexpressing cells (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). To avoid the growth arrest and cell death associated with full-length HEB (HEBCan) overexpression (<xref ref-type="bibr" rid="bib25">Engel and Murre, 2004</xref>; <xref ref-type="bibr" rid="bib95">Wang et al., 2010</xref>), we used a construct encoding HEBAlt, a truncated form that activates E protein target genes without impairing cell viability (<xref ref-type="bibr" rid="bib95">Wang et al., 2010</xref>; <xref ref-type="bibr" rid="bib94">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib100">Yoganathan et al., 2022</xref>).</p><p>Upon overnight stimulation with anti-TAC, both control and HEB-expressing cells downregulated CD25 to similar degrees, as assessed by flow cytometry, confirming effective CD3-mediated signaling (<xref ref-type="fig" rid="fig7">Figure 7C and E</xref>). Quantitative RT-PCR (qRT-PCR) analysis showed that <italic>Id3</italic> expression was modestly elevated in unstimulated HEB-expressing cells compared to controls, and stimulation of control cells upregulated <italic>Id3</italic> levels to a greater degree (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Notably, <italic>Id3</italic> expression in stimulated cells expressing HEB was much higher than either HEB or stimulation alone, and exceeded the sum of these two conditions, indicating a synergistic interaction. These results demonstrate that HEB can amplify <italic>Id3</italic> induction in response to TCR signaling, potentially through cooperative interaction with TCR-induced factors such as Egr2.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>HEB and Id3 are both critical for T cell development, but their distinct functions in fetal γδ T cell development had not been resolved. Here, we show that HEB controls expression of genes involved in γδTCR signaling and induces a transcriptional program that primes γδ T cell precursors for γδT17 differentiation. Furthermore, HEB collaborates with TCR-dependent factors to upregulate <italic>Id3</italic>, which enables γδT17 cell maturation and inhibits the αβ T cell fate. Together, these findings define a sequence of regulatory states governed by the E/Id axis that orchestrate γδ T cell lineage commitment and the differentiation of functional γδT17 cells.</p><p>TCR signal strength is tightly linked to specific combinations of Vγ and Vδ chains expressed on fetal γδ T cells, which serve as critical drivers of γδ T cell fate and functional programming (<xref ref-type="bibr" rid="bib16">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib27">Fahl et al., 2018b</xref>; <xref ref-type="bibr" rid="bib68">Munoz-Ruiz et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Scaramuzzino et al., 2022</xref>). We found that HEB is required for the expression of TRGV4 and TRDV5. These genes encode the Vγ4 Vδ5 TCR, which supports γδT17 cell differentiation (<xref ref-type="bibr" rid="bib49">Kashani et al., 2015</xref>). While TRGV4 is known to be regulated by E proteins (<xref ref-type="bibr" rid="bib5">Bain et al., 1999</xref>; <xref ref-type="bibr" rid="bib42">In et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Nozaki et al., 2011</xref>), the requirement for HEB in TRDV5 regulation is newly appreciated. Notably, the TRD locus contains E2A-dependent insulators that limit TRDV4 expression to the fetal thymus (<xref ref-type="bibr" rid="bib36">Hao and Krangel, 2011</xref>). Whether these are also HEB-dependent, and whether they impact TRDV expression among fetal γδ T cell subsets, remains to be determined.</p><p>Our analysis identified known E protein target genes, including components of the TCR signaling pathway (<italic>Cd3d</italic>, <italic>Cd3g</italic>, <italic>Lat</italic>, <italic>Zap70</italic>) (<xref ref-type="bibr" rid="bib12">Braunstein and Anderson, 2011</xref>; <xref ref-type="bibr" rid="bib66">Miyazaki et al., 2017</xref>) and chemokine receptors (<italic>Cxcr5</italic>, <italic>Cxcr4</italic>, <italic>Ccr9</italic>) (<xref ref-type="bibr" rid="bib47">Kadakia et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Krishnamoorthy et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Miyazaki et al., 2011</xref>), validating the experimental approach. Moreover, we found that a suite of γδT17-specific genes were also HEB-dependent, including <italic>Blk</italic> and <italic>Syk</italic>, which are γδT17 cell-specific mediators of TCR signaling. We also noted that several inhibitors of TCR signaling were decreased, including <italic>Pdcd1</italic> (encodes PD-1), <italic>Nfbia</italic> (encodes Ikappaα), and <italic>Sh2d2a</italic> (encodes TSAd). All of these inhibitors are regulated post-translationally, suggesting a role for HEB in inducing T lineage-specific pathways that enable both positive and negative regulation of TCR signal transduction.</p><p>Our studies show that Id3 limits αβ lineage potential even in the presence of HEB, suggesting that HEB restricts the αβ program primarily by upregulating <italic>Id3</italic>. In contrast, the early γδT cell program is upregulated in Id3-KO mice, indicating that Id3 is not required for this function. A third E/Id dynamic operates during γδT17 maturation, which requires Id3 independently of HEB. Sox13 has been shown to initiate a cascade of regulatory events that induce <italic>Blk</italic> and <italic>Maf</italic> during γδT17 development (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Pokrovskii et al., 2020</xref>). However, our work indicates that Sox13 is not sufficient to upregulate γδT17 maturation factors like <italic>Zbtb16</italic> and <italic>Maf</italic> in the absence of Id3, implying an E protein-dependent brake on γδT17 maturation. This highlights a decoupling between lineage specification and effector maturation, supporting the two-step model of γδ T cell development (<xref ref-type="bibr" rid="bib13">Buus et al., 2016</xref>).</p><p>HEB and E2A can partially compensate for each other in the context of lymphocyte development, complicating interpretations of single gene knockouts (<xref ref-type="bibr" rid="bib9">Barndt et al., 2000</xref>; <xref ref-type="bibr" rid="bib107">Zhuang et al., 1998</xref>). This has been especially well characterized in αβ-T cell development, in which a lack of E2A leads to partial blocks at the ETP and DP to SP transitions (<xref ref-type="bibr" rid="bib41">Ikawa et al., 2006</xref>; <xref ref-type="bibr" rid="bib44">Jones and Zhuang, 2007</xref>), whereas HEB deficiency impairs the ISP to DP transition (<xref ref-type="bibr" rid="bib8">Barndt et al., 1999</xref>). Mice conditionally lacking both HEB and E2A have more severe phenotypes (<xref ref-type="bibr" rid="bib45">Jones and Zhuang, 2011</xref>), especially at the ETP to DN2 transition when T cell lineage identity is being established (<xref ref-type="bibr" rid="bib66">Miyazaki et al., 2017</xref>), and at the DN2 to DN3 transition, when T lineage commitment occurs (<xref ref-type="bibr" rid="bib97">Wojciechowski et al., 2007</xref>). Indeed, early loss of HEB alone renders T cell precursors more open to divergence to non-T lineages, even at the DN3 stage (<xref ref-type="bibr" rid="bib12">Braunstein and Anderson, 2011</xref>). Our laboratory and others identified ‘DN1-like’ cells in the thymus of E protein-deficient and Id1-overexpressing mice, which were later identified as ILC2s (<xref ref-type="bibr" rid="bib11">Berrett et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Miyazaki et al., 2025</xref>; <xref ref-type="bibr" rid="bib66">Miyazaki et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Qian et al., 2019</xref>). The TCRγ rearrangements observed in thymic ILC2s and peripheral ILC2s in normal mice (<xref ref-type="bibr" rid="bib74">Pankow and Sun, 2022</xref>; <xref ref-type="bibr" rid="bib79">Qian et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Shin et al., 2020</xref>) support a critical role for E proteins in lineage divergence, rather than outgrowth of alternative lineages, even prior to the αβ/γδ T cell branch point.</p><p>Our findings are consistent with a selective requirement for HEB factors in γδT17 cell differentiation. Intriguingly, we observed that γδT1 lineage cells express <italic>Tcf3</italic> (E2A) and <italic>Id3</italic> but not <italic>Tcf12</italic> (HEB). Furthermore, <italic>Tcf3</italic> levels remained constant under conditions of HEB deficiency in all γδ T cell subsets. These results suggest that while E2A is insufficient for γδT17 development, it may be required and sufficient for γδT1 development. Overall, our analysis suggests a strong division of labor between HEB and E2A in regulating the γδT17 and γδT1 fates, respectively.</p><p>It is possible that Id3 is needed after γδ T cell specification to inhibit E2A-driven inhibitors of γδT17 maturation. Possible candidates include positive regulators of γδT1 differentiation, such as T-bet (<italic>Tbx21</italic>) or Eomes. These transcription factors participate in negative cross-regulatory loops with γδT17 regulators such as Runx1, RORγt, and AP-1 factors, which help to stabilize γδ T cell subset lineage identity (<xref ref-type="bibr" rid="bib76">Parker et al., 2025</xref>). Additionally, transiently expressed HEB-dependent transcription factors such as <italic>Etv5</italic> and <italic>Sox5</italic> may act as a checkpoint for γδT17 maturation, to be released upon <italic>Id3</italic> upregulation.</p><p>The TCR signal strength model posits that strong signals induce high levels of Egr factors, which in turn induce high levels of Id3 (<xref ref-type="bibr" rid="bib34">Haks et al., 2005</xref>; <xref ref-type="bibr" rid="bib53">Lauritsen et al., 2009</xref>). Our data add an important new dimension to this paradigm, proposing that the lower Egr2 levels induced by weaker γδTCR signaling require cooperation with HEB/E2A to upregulate <italic>Id3</italic> expression (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A</xref>). This model is supported by the ChIP-seq data, which confirms HEB and E2A binding at the <italic>Id3</italic> locus, at regions also bound by Egr2, and gain-of-function studies, which show that HEB synergizes with CD3 signals to amplify <italic>Id3</italic> expression. However, it is important to note that additional studies will be needed to confirm whether HEB and E2A collaborate with Egr2 in a temporally coordinated fashion during γδ T cell specification. Both HEB and E2A are pioneering factors and can increase locus accessibility of genes involved in lymphoid development, such as <italic>Foxo1</italic> (<xref ref-type="bibr" rid="bib96">Welinder et al., 2011</xref>). Interestingly, we found that HEB/E2A peaks in the <italic>Id3</italic> locus are diminished in cells from HEB cKO mice relative to WT, particularly at the DN3 stage. Therefore, HEB may play an important role in epigenetically priming the <italic>Id3</italic> locus prior to TCR signaling.</p><p>Our data is consistent with a partial compensation for Id3 by Id2, less effectively during γδ T cell commitment, and more fully during late γδT17 maturation, when <italic>Id2</italic> is normally expressed. This is consistent with the observation that Id3 supports transient developmental transitions, while Id2 stabilizes innate-like transcriptional states (<xref ref-type="bibr" rid="bib4">Anderson, 2022</xref>). Since <italic>Id2</italic> is a direct target of E2A (<xref ref-type="bibr" rid="bib85">Schwartz et al., 2006</xref>), the upregulation of <italic>Id2</italic> in <italic>Id3</italic>-deficient precursors likely reflects increased E protein activity. Thus, HEB, Id3, and Id2 participate in negative regulatory loops that allow transient HEB activity and <italic>Id3</italic> expression, followed by stabilization of the innate γδT17 gene network by Id2 (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2B</xref>). Understanding how Id3 and Id2 differentially regulate the timing and magnitude of E protein activity and whether they have different impacts on E2A/E2A homodimers versus HEB/E2A heterodimers remains to be addressed.</p><p>There are limitations to our study. Our analyses focused on E18 γδ T cells, which reflect γδT17-biased fetal development and may not capture functions of HEB or Id3 at other stages. We previously showed that HEB cKO mice have defects in the production of functional γδT17 cells in neonatal thymus (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>). We also found that γδ T cells from HEB cKO mice exhibited a diminished capacity for IL-17 production in adult lungs and spleen γδ T cells. While the adult thymus does not support the development of fully functional innate γδ T cells (<xref ref-type="bibr" rid="bib16">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Haas et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Kashani et al., 2015</xref>), it does contain γδTCR<sup>+</sup> cells with activated <italic>Sox-Maf-Rorc</italic> gene networks (<xref ref-type="bibr" rid="bib99">Yang et al., 2023</xref>). In addition, we have not yet addressed the roles of HEB and Id3 in TCR-independent development of a subset of early fetal-derived Vγ4 γδ T cells (<xref ref-type="bibr" rid="bib91">Spidale et al., 2018</xref>). Importantly, the specific contributions of HEBAlt and HEBCan isoforms remain unresolved, as both were deleted in our conditional HEB model. Further studies of γδ T cell development in the neonatal and adult thymus of HEB cKO, as well as HEBAlt KO and HEBCan KO mice, are underway.</p><p>In summary, our studies have identified multiple interlinked transcriptional circuits that require E proteins and Id factors during γδ T cell development. HEB induces Id3, which then inhibits E protein activity. In the absence of Id3, HEB and E2A activity persist, inducing compensatory Id2 expression. Since <italic>Id3</italic> expression is self-limiting through E protein suppression, the HEB-Id3 interactions result in a negative feedback loop. Thus, HEB plays dual roles in establishing γδ lineage identity and initiating γδT17 differentiation via Id3. Future work should clarify the direct transcriptional targets and co-factors of HEB, and how dynamic levels of HEB, Id3, and Id2 coordinate γδ T cell fate decisions.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tcf12</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">GenBank:NM_011544.3</td><td align="left" valign="bottom">Encodes HEB isoforms HEBAlt and HEBCan</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Id3</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">GenBank:NM_008321.3</td><td align="left" valign="bottom">Encodes Id3</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, C57BL/6, male and female)</td><td align="left" valign="bottom"><italic>Tcf12</italic><sup>fl/fl</sup> (HEB<sup>fl/fl</sup>)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17442955/">17442955</ext-link></td><td align="left" valign="bottom">Not commercially available, provided upon request</td><td align="left" valign="bottom">Conditional <italic>Tcf12</italic> floxed allele; bred to Vav-iCre to generate HEB cKO mice</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, C57BL/6, male and female)</td><td align="left" valign="bottom">Vav-iCre</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">IMSR:JAX:008610; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:008610">IMSR_JAX:008610</ext-link></td><td align="left" valign="bottom">B6.Cg-Commd10Tg(Vav1-icre)A2Kio/J; hematopoietic Cre driver</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, C57BL/6, male and female)</td><td align="left" valign="bottom"><italic>Id3</italic>-KO (<italic>Id3</italic>-RFP)</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">IMSR:JAX:010983; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:010983">IMSR_JAX:010983</ext-link></td><td align="left" valign="bottom">B6;129S-Id3tm1Pzg/J; backcrossed to C57BL/6 for 8 generations</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>, C57BL/6, male and female)</td><td align="left" valign="bottom"><italic>Rag2</italic>-KO</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="left" valign="bottom">IMSR:JAX:008449; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:IMSR_JAX:008449">IMSR_JAX:008449</ext-link></td><td align="left" valign="bottom">B6.Cg-Rag2tm1.1Cgn/J; lacks mature T and B cells</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">SCID.adh</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10452996/">10452996</ext-link></td><td align="left" valign="bottom">Not commercially available, provided upon request</td><td align="left" valign="bottom">Pro-T cell line derived from SCID mice expressing a hybrid hIL2-CD3e signaling molecule; verified by flow cytometry (CD44+/–, CD25+) and downregulation of CD25 upon stimulation</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">MIGR1-HEBAlt retroviral vector</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20826759/">20826759</ext-link></td><td align="left" valign="bottom">Not commercially available, provided upon request</td><td align="left" valign="bottom">MSCV retroviral vector encoding HEBAlt downstream of an IRES-GFP; used to transduce SCID.adh cells; HEBAlt corresponds to Tcf12 transcript variant 4 (GenBank:NM_001253864.1)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-CD4 (rat monoclonal, clone GK1.5)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:12-0041-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_465506">AB_465506</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-mouse CD8a (rat monoclonal, clone 53–6.7)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 100705;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_312744">AB_312744</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BUV737 anti-CD4 (rat monoclonal, clone GK1.5)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:367-0041-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2895921">AB_2895921</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC-eFluor 780 anti-mouse CD8a (rat monoclonal, clone 53-6.7)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:47-0081-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1272185">AB_1272185</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE-Cy7 anti-mouse CD25 (rat monoclonal, clone PC61.5)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:551071;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_394031">AB_394031</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 700 anti-mouse CD3e (Armenian hamster monoclonal, clone 145-2C11)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat#:100236;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2561455">AB_2561455</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BV605 anti-mouse CD73 (rat monoclonal, clone TY/11.8)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:752734</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BUV496 anti-mouse CD24 (rat monoclonal, clone M1/69)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:612953</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BUV737 anti-mouse CD27 (hamster monoclonal, clone LG.7F9)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#: 612831</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-mouse PLZF (mouse monoclonal, clone R17-809)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:564850</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">eFluor 450 anti-mouse c-Maf (mouse monoclonal, clone sym0F1)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:48-9855-42; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2762608">AB_2762608</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse IL-17A (rat monoclonal, clone eBio17B7)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:17-7177-81</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP-eFluor 710 anti-mouse TCRgd (Armenian hamster monoclonal, clone GL3)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:46-5711-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2016707">AB_2016707</ext-link></td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BV421 anti-mouse TCRgd (hamster monoclonal, clone GL3)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:562892</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">BV711 anti-mouse Vgamma1.1 TCR (Armenian hamster monoclonal, clone 2.11)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:745456</td><td align="left" valign="bottom">(FACS, 1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-mouse Vgamma3 (rat monoclonal, clone 536)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat#:137504;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2562450">AB_2562450</ext-link></td><td align="left" valign="bottom">(FACS, 1:200); commercial anti-Vgamma3 is referred to as Vgamma5 in the manuscript</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-mouse Vgamma3 (rat monoclonal, clone 536)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat#:553229;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_394747">AB_394747</ext-link></td><td align="left" valign="bottom">(FACS, 1:200); commercial anti-Vgamma3 is referred to as Vgamma5 in the manuscript</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE-Cy7 anti-mouse Vgamma2 (Armenian hamster monoclonal, clone UC3-10A6)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:25-5828-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2573474">AB_2573474</ext-link></td><td align="left" valign="bottom">(FACS, 1:200); commercial anti-Vgamma2 is referred to as Vgamma4 in the manuscript</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">APC anti-mouse Vgamma2 (Armenian hamster monoclonal, clone UC3-10A6)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat#:137707;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2563942">AB_2563942</ext-link></td><td align="left" valign="bottom">(FACS, 1:200); commercial anti-Vgamma2 is referred to as Vgamma4 in the manuscript</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TAC/anti-human IL-2R alpha (mouse monoclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33535043/">33535043</ext-link></td><td align="left" valign="bottom">Not commercially available, provided by request</td><td align="left" valign="bottom">Plate-bound at 5 µg/mL; binding to human IL-2Ra on SCID.adh cells mimics pre-TCR signaling</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-E2A (rabbit polyclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33535043/">33535043</ext-link></td><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">(ChIP-seq, 10 µg/IP); affinity-purified rabbit polyclonal sera raised against the last 12 amino acids of the E2A C-terminus; see previously described ChIP-seq methods</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HEB (rabbit polyclonal)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33535043/">33535043</ext-link></td><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">(ChIP-seq, 10 µg/IP); affinity-purified rabbit polyclonal sera raised against the last 12 amino acids of the HEB C-terminus; see previously described ChIP-seq methods</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Id3 qRT-PCR primer set</td><td align="left" valign="bottom">Integrated DNA Technologies</td><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Forward: <named-content content-type="sequence">CTGTCGGAACGTAGCCTGG</named-content>; Reverse: <named-content content-type="sequence">GTGGTTCATGTCGTCCAAGAG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Actb (beta-actin) qRT-PCR primer set</td><td align="left" valign="bottom">Integrated DNA Technologies</td><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Forward: <named-content content-type="sequence">ATGGTGGGAATGGGTCAGAA</named-content>; Reverse: <named-content content-type="sequence">TCTCCATGTCGTCCCAGTTG</named-content></td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">LIVE/DEAD Fixable Aqua Dead Cell Stain Kit, for 405 nm excitation</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:L34957</td><td align="left" valign="bottom">Flow cytometry</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SuperScript III First-Strand Synthesis System</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#:18080051</td><td align="left" valign="bottom">cDNA synthesis for qRT-PCR</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Chromium Next GEM Single Cell 5' Kit v2 (Dual Index)</td><td align="left" valign="bottom">10x Genomics</td><td align="left" valign="bottom">Cat#:PN-1000263</td><td align="left" valign="bottom">scRNA-seq</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Chromium Next GEM Single Cell 3' Kit v2 (Dual Index)</td><td align="left" valign="bottom">10x Genomics</td><td align="left" valign="bottom">Cat#:PN-1000268</td><td align="left" valign="bottom">scRNA-seq</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PowerUp SYBR Green Master Mix</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:A25742</td><td align="left" valign="bottom">qRT-PCR</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">FIX &amp; PERM Cell Permeabilization Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:88-8824-00</td><td align="left" valign="bottom">Catalog number reported in supplied file</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Foxp3/Transcription Factor Staining Buffer Set</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:00-5523-00</td><td align="left" valign="bottom">Intracellular flow cytometry</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TRIzol Reagent</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#:15596026</td><td align="left" valign="bottom">RNA extraction</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Brefeldin A Solution (1000×)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat#:00-4506-51</td><td align="left" valign="bottom">Inhibition of cytokine secretion</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BD FACSDiva Software</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_001456">SCR_001456</ext-link></td><td align="left" valign="bottom">Flow cytometry acquisition and analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo, LLC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom">Flow cytometry analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR (v2.5.2b)</td><td align="left" valign="bottom">Dobin et al.; SciCrunch</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_004463">SCR_004463</ext-link></td><td align="left" valign="bottom">FASTQ alignment to the mm39 genome</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SAMTOOLS (v0.1.19)</td><td align="left" valign="bottom">HTSlib/SciCrunch</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002105">SCR_002105</ext-link></td><td align="left" valign="bottom">BAM file processing</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BEDTools (v2.25.0)</td><td align="left" valign="bottom">bedtools/SciCrunch</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_006646">SCR_006646</ext-link></td><td align="left" valign="bottom">BED file processing</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cell Ranger (v1.1.7)</td><td align="left" valign="bottom">10x Genomics</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_017344">SCR_017344</ext-link></td><td align="left" valign="bottom">Read alignment and matrix generation</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat (v4.4)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Hao et al., 2021</xref>; Satija Lab</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016341">SCR_016341</ext-link></td><td align="left" valign="bottom">Single-cell RNA-seq analysis; R markdown files used for downstream analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">KEGG</td><td align="left" valign="bottom">Kanehisa Laboratories; SciCrunch</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_012773">SCR_012773</ext-link></td><td align="left" valign="bottom">Pathway analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cistrome Data Browser</td><td align="left" valign="bottom">Cistrome</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_000242">SCR_000242</ext-link></td><td align="left" valign="bottom">Retrieval of public ChIP-seq and ATAC-seq datasets</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Integrative Genomics Viewer (IGV)</td><td align="left" valign="bottom">Broad Institute</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_011793">SCR_011793</ext-link></td><td align="left" valign="bottom">Visualization of genome-aligned sequencing data</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ShinyGO</td><td align="left" valign="bottom">ShinyGO</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_019213">SCR_019213</ext-link></td><td align="left" valign="bottom">Gene ontology analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Immunological Genome Project (ImmGen)</td><td align="left" valign="bottom">ImmGen</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_021792">SCR_021792</ext-link></td><td align="left" valign="bottom">Immune cell gene expression database</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Anti-CD4 MicroBeads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">Cat#:130-117-043</td><td align="left" valign="bottom">MACS enrichment</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Anti-CD8a MicroBeads</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">Cat#:130-117-044</td><td align="left" valign="bottom">MACS enrichment</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental design and statistical analysis</title><p>The overall goal of this study was to understand how HEB transcription factors regulate the transcriptional networks required for the development of IL-17-producing γδ T cells. The subjects of these studies were genetically modified mice. The experimental variable was the genotype of the mice. For a given genotype, experimental mice were chosen randomly based on the availability of animals and littermate controls. Mice of both sexes were used. No sex differences were apparent; therefore, data were pooled. Experiments were done two to three times, depending on the number of mice available for each experiment, and results were pooled for statistical analysis for a total n of ≥3. Each biological replicate (mouse) is depicted as an open circle on the bar graphs. The investigators were not blinded to allocation during experiments and outcome assessment, except when fetal thymocytes were analyzed by flow cytometry prior to genotyping. Groups were unpaired, with similar variances, and all comparisons between genotypes were made within a given subset. Therefore, we assessed the significance of each comparison of mean values using an unpaired two-tailed classic Student’s t-test, with p&lt;0.05 considered statistically significant. Error bars represent standard error of the mean (SEM) values.</p></sec><sec id="s4-2"><title>Mice</title><p>Genetically modified mice were used in this study. <italic>Tcf12<sup>fl/fl</sup></italic> mice have loxP sites flanking the helix-loop-helix dimerization domain, which is shared by all HEB isoforms (<xref ref-type="bibr" rid="bib94">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib97">Wojciechowski et al., 2007</xref>). These mice were bred to <italic>Vav-iCre</italic> transgenic mice (JAX stock #008610) (<xref ref-type="bibr" rid="bib20">de Boer et al., 2003</xref>), which deletes regions flanked by loxP sites in all hematopoietic cells (<xref ref-type="bibr" rid="bib90">Siegemund et al., 2015</xref>), to generate <italic>Tcf12<sup>fl/fl</sup> Vav-iCre</italic> (HEB cKO) mice, as previously described (<xref ref-type="bibr" rid="bib42">In et al., 2017</xref>; <xref ref-type="bibr" rid="bib96">Welinder et al., 2011</xref>). All experimental HEB cKO mice were obtained from timed matings of <italic>Tcf12<sup>fl/fl</sup></italic> x <italic>Tcf12<sup>fl/fl</sup> Vav-iCre</italic> mice, enabling parallel analysis with WT (no Cre) littermates. <italic>Id3</italic>-deficient mice (Id3-KO) lacked <italic>Id3</italic> in all cells due to a knock-in/knockout allele in which the <italic>Id3</italic> coding sequence was replaced with red fluorescent proteins (RFP) (JAX strain # 010983, B6;129S-<italic>Id3<sup>tm1Pzg</sup></italic>/J). RFP was not detected in our analyses due to quenching during intracellular staining. Id3-KO mice were acquired on the E29/B6 background and bred onto the C57Bl/6 background for 8 generations. Id3<sup>+/-</sup> mice were timed mated together to produce WT and Id3-KO littermates. <italic>Rag2</italic><sup>-/-</sup> mice were obtained from Jackson Labs (JAX strain # 008449, B6.Cg-Rag2tm1.1Cgn/J). Fetal thymocytes were analyzed at E18, and adult mice were analyzed at 6–9 weeks of age. Mice were bred and maintained in the Comparative Research Facility of the Sunnybrook Research Institute (Toronto, ON, Canada) under specific pathogen-free conditions. All animal procedures were approved by the Sunnybrook Research Institute Animal Care Committee under animal user protocol (AUP) 22204 and in compliance with the Canadian Council of Animal Care guidelines.</p></sec><sec id="s4-3"><title>Timed matings and embryo harvest</title><p>Timed matings were performed by setting up mating pairs (day 0) and separating them ~16 hr later. Embryos were harvested after 18 days (E18). Fetal thymuses were dissected and individually pressed through a 40 µm mesh with a syringe plunger to create single-cell suspensions. Cells were resuspended in 1× HBSS/BSA for sorting or flow cytometry. Embryos were processed and analyzed separately, and tail tissue was collected for genotyping. Genotyping was performed as previously described for HEB cKO mice (<xref ref-type="bibr" rid="bib97">Wojciechowski et al., 2007</xref>). Id3-KO mice were genotyped using the protocol described for the B6;129S-<italic>Id3<sup>tm1Pzg</sup></italic>/J strain on the Jackson Laboratories website.</p></sec><sec id="s4-4"><title>Flow cytometry</title><p>Antibodies were purchased from eBiosciences (San Diego, CA, USA), BioLegend (San Diego, CA, USA), and BD Biosciences (Mississauga, ON, Canada). For flow cytometry, cells were washed and incubated with Fc blocking antibody (BD Biosciences), followed by extracellular staining for surface CD4 (clone GK1.5), CD8α (clone 53–6.7), CD3 (clone 145-2C11), TCRγδ (clone GL3), Vγ4 (Vγ2; clone UC3-10A6), Vγ5 (Vγ3; clone 536), Vγ1 (Vγ1.1; clone 2.11), CD27 (clone LG3-1A10), CD24 (clone M1/69), CD73 (clone TY11.8), and CD25 (clone PC615). To assess functional capacities, cells were stimulated by incubation for 4 hr with PMA (50 ng/ml) and ionomycin (500 ng/ml) in the presence of Brefeldin A (5 mg/ml; eBioscience), washed with 1× HBSS/BSA, and incubated with Fc block before staining for surface epitopes. Cells were then fixed and permeabilized (Fix and Perm Cell Permeabilization Kit; eBioscience) and stained with antibodies against IL-17A (clone eBio17B7). For intracellular transcription factor staining, the cells were fixed, permeabilized (FoxP3 Staining Kit, eBioscience), and stained for MAF (clone sym0F1) and PLZF (clone R17-809). All flow cytometric analyses were performed using Becton-Dickinson (BD) LSRII, Fortessa, or SymphonyA5-SE cytometers. FACSDiva and FlowJo software were used for analysis. Sorting was performed on BD ARIA and BD Fusion sorters.</p></sec><sec id="s4-5"><title>Cell culture</title><p>SCID.adh cells, which have been engineered to express a surface human IL-2Ra (TAC):CD3epsilon chimeric signaling molecule on the surface, were cultured as previously described (<xref ref-type="bibr" rid="bib3">Anderson et al., 2002</xref>). SCID.adh cell line identity was confirmed by flow cytometry phenotyping of CD44 and CD25 expression and response to stimulation with downregulation of CD25, and the cells tested negative for mycoplasma. SCID.adh cells were transduced with MIGR1 encoding GFP only (control) or MIGR1 encoding GFP and HEBAlt. GFP<sup>+</sup> cells were sorted, expanded, and cultured overnight on plates coated with anti-TAC antibody at 5 µg/ml in 500 µl of PBS or PBS only as control. Cells were analyzed by flow cytometry for expression of CD25 and for mRNA expression of <italic>Id3</italic> by qRT-PCR.</p></sec><sec id="s4-6"><title>RNA extraction and qRT-PCR</title><p>Total RNA was extracted from cells using TRIzol Reagent (Invitrogen) and reverse-transcribed into complementary DNA using Superscript III (Invitrogen). Reactions for qRT-PCR were prepared using PowerUp SYBR Green Master Mix (Thermo Fisher) and 0.5 μM of primers. Primers (5′ to 3′) were as follows: β-actin forward: <named-content content-type="sequence">ATGGTGGGAATGGGTCAGAA</named-content>, β-actin reverse: <named-content content-type="sequence">TCTCCATGTCGTCCCAGTTG</named-content>, Id3 forward: <named-content content-type="sequence">CTGTCGGAACGTAGCCTGG</named-content>, Id3 reverse: <named-content content-type="sequence">GTGGTTCATGTCGTCCAAGAG</named-content>. The qRT-PCR was run and analyzed using an Applied Biosystems 7500 Fast Real-Time PCR System (Thermo Fisher) and a QuantStudio 5 Real-Time PCR System (Thermo Fisher). Values from the qRT-PCRs were normalized to β-actin values, and relative expression values were calculated by the delta Ct method.</p></sec><sec id="s4-7"><title>scRNA-seq of WT and HEB cKO γδ T cells</title><p>E18 fetal thymocytes from HEB cKO mice were incubated with Fc block for 30 min on ice. Small aliquots from each sample were stained with CD4, CD8, and CD3 to assess genotypes by flow cytometry, with a lack of DP indicating HEB deletion, and genotypes were verified by PCR. Five WT and five HEB cKO littermates were pooled by genotype, stained, and sorted for TCRγδ<sup>+</sup>CD3<sup>+</sup> cells. Samples were not hash-tagged as this technology was not available at the time of the experiment. Fifty thousand cells per sample were loaded onto the 10× Chromium controller, and barcoded libraries were generated using the Chromium Next GEM Single Cell 5' Kit v2 (Dual Index) (10x Genomics) at the Princess Margaret Genomics Facility (Toronto, ON, Canada). Next-generation Illumina sequencing was performed to a depth of ~30,000 reads per cell. The estimated number of cells sequenced was ~3300 for WT and ~5500 for HEB cKO samples.</p></sec><sec id="s4-8"><title>scRNA-seq of WT and Id3-KO DN fetal thymocytes</title><p>E18 fetal thymuses from Id3-KO mice were dissected from embryos, pressed through mesh as above, and incubated with Fc block. Embryos were genotyped by PCR, and thymocytes were pooled according to genotype (3 WT and 3 Id3-KO mice). DN cells were enriched by magnetic sorting using anti-CD4 and anti-CD8 microbeads according to the manufacturer’s instructions (Miltenyi Biotech). Flow-through (CD4<sup>-</sup>CD8<sup>-</sup>) cells were processed in-house using the Chromium Next GEM Single Cell 3' Kit v2 (Dual Index) (10x Genomics). Next-generation sequencing was performed using the Illumina platform to a depth of ~100,000 reads per cell. The estimated number of cells sequenced for each sample was ~3700.</p></sec><sec id="s4-9"><title>scRNA-seq data analysis of WT and HEB cKO γδ T cells</title><p>FASTQ raw data files were aligned to the mm10 genome using the STAR aligner (STAR v2.5.2b). Cell Ranger (v1.1.7; 10x Genomics) (<xref ref-type="bibr" rid="bib105">Zheng et al., 2017</xref>) was used to generate matrix files, which were analyzed using programs in R-Seurat version 4.4 (<xref ref-type="bibr" rid="bib37">Hao et al., 2021</xref>), as detailed in the R-Markdown files. WT and HEB cKO datasets were processed for quality control by excluding cells with more than 7% mitochondrial genes, less than 1000 unique genes, and/or less than 4000 transcripts, resulting in 1272 WT cells and 1951 HEB cKO cells for further analysis. Filtered WT and HEB cKO datasets were merged, and SCTransform was applied to the merged dataset. Cell cycle regression was performed to mitigate the influence of cell cycle heterogeneity on clustering, and cells expressing high levels of <italic>Lyz2</italic> were excluded to remove most myeloid cells. PCA was performed (RunPCA) and used to compute a nearest neighbor graph (FindNeighbors) and identify clusters (FindClusters). UMAP plots were generated using RunUMAP and displayed using DimPlot_scCustom. FindMarkers was used to identify the top 10 most differentially expressed genes between clusters.</p></sec><sec id="s4-10"><title>Generation of gene lists and module scores</title><p>To construct an unbiased and comprehensive list of genes diagnostic for different stages and lineages of γδ T cell development, we collected lists of differentially expressed genes from eight publications characterizing γδ T cell subsets in the fetal thymus, adult thymus, and adult peripheral tissues (<xref ref-type="bibr" rid="bib22">du Halgouet et al., 2024</xref>; <xref ref-type="bibr" rid="bib43">Inácio et al., 2025</xref>; <xref ref-type="bibr" rid="bib59">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Mistri et al., 2024</xref>; <xref ref-type="bibr" rid="bib71">Narayan et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Pokrovskii et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Spidale et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Yang et al., 2023</xref>). Genes were filtered to remove those involved in cell cycle and metabolism, as well as NK cell receptor genes. Lists were combined, duplicates were removed, and a final list of 87 genes was obtained (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). This list was used for computation of the top 10 genes per cluster that were most differentially expressed from all other clusters, visualized as a Clustered DotPlot. Comparisons with the source literature and the Immunological Genome Project (<xref ref-type="bibr" rid="bib40">Heng et al., 2008</xref>) were used to categorize the clusters. γδTe1 and γδTe2 represent two types of early γδ T cell subsets with random assignments into ‘1’ and ‘2’.</p><p>As developmental stages are continuous, not discrete, some genes were present in more than one module; scores were based on all genes in each module. Genes in each module are listed below.</p><list list-type="simple" id="list1"><list-item><p>gdTe1: <italic>Ccr9, Sox13, Cpa3, Etv5, Sox5, Tox2, Ccr2, Igfbp4, Blk, Lmo4, Slamf1, Ifngr1, Rorc, Maf, Icos</italic></p></list-item><list-item><p>gdTe2: <italic>Hivep3, Cd28, Themis, Slamf6, Sell, Igfbp4, Cd24a, Gzma</italic></p></list-item><list-item><p>gdT17p: <italic>Blk, Il17re, Vdr, Il17a, Lmo4, Slamf1, Ifngr1, Rorc, Maf, Icos</italic></p></list-item><list-item><p>gdT17: <italic>Il18r1, Il7r, Id2, Il23r, Il1r1, Cd44</italic></p></list-item><list-item><p>gdT1p: <italic>Klf2, Nrgn, Cd2, Ms4a4b, Prkch, Nr4a1, Id3</italic></p></list-item><list-item><p>gdT1: <italic>S1pr1, Eomes, Slamf7, Tyrobp, Ifitm1, Fcer1g, Tbx21, Gzmb</italic></p></list-item><list-item><p>abT: <italic>Cd8a, Notch1, Cd8b1, Rag1, Rag2, Rmnd5a</italic></p></list-item></list><p>Module location and intensity in WT versus HEB cKO cells were visualized using split UMAPs. Comparisons of the expression of single genes between WT and HEB cKO clusters were shown using split violin plots. To compare clusters 1 and 4, we performed FindMarkers, using the Wilcox test. Differentially expressed genes were displayed using an Enhanced Volcano Plot, with significance set at log<sub>2</sub>fold change&gt;0.5 and –log<sub>10</sub>p&lt;10<sup>26</sup>.</p></sec><sec id="s4-11"><title>scRNA-seq data analysis of WT and Id3-KO DN thymocytes</title><p>The following analyses were conducted on the Id3-KO dataset. FASTQ raw data files were aligned to the mm39 genome using the STAR aligner (STAR v2.5.2b), and Cell Ranger was used to generate matrix files, which were analyzed using programs in R-Seurat. Cells were computationally filtered as described above in the HEB cKO dataset, resulting in 2323 WT cells and 2893 Id3-KO cells for further analysis. Datasets were merged and subjected to SCTransform as above. PCA plots were generated and used to construct UMAP plots depicting clusters in merged datasets and distribution of WT versus Id3-KO cells within each cluster by UMAP (see R-markdown file). Feature plots and violin plots were used to identify clusters with γδ T cell characteristics, which were subsetted using FindClusters. ClusteredDotPlot was used to visualize the top eight most differentially expressed genes within the curated gene set described above. Split violin plots were generated to show relative expression of early and late γδ T cell genes in WT versus HEB cKO cells within each cluster.</p></sec><sec id="s4-12"><title>ATAC-seq</title><p>Thymuses were dissected from adult <italic>Rag2</italic><sup>-/-</sup>, WT, and HEB cKO mice, pressed through mesh as above, and incubated with Fc block. WT and HEB cKO DN cells were enriched by magnetic sorting using anti-CD4 and anti-CD8 microbeads according to the manufacturer’s instructions (Miltenyi Biotech). Flow-through (CD4<sup>-</sup>CD8<sup>-</sup>) cells were stained and flow-sorted into two populations: DN3 (CD4<sup>-</sup>CD8<sup>-</sup>CD44<sup>-</sup>CD25<sup>+</sup>) cells and DN4 (CD4<sup>-</sup>CD8<sup>-</sup>CD44<sup>-</sup>CD25<sup>-</sup>). <italic>Rag2</italic><sup>-/-</sup> DN3 cells were obtained from <italic>Rag2</italic><sup>-/-</sup> mice, which do not develop past the DN3 stage, restricting the <italic>Rag2</italic><sup>-/-</sup> DN3 population to pre-selection cells (<xref ref-type="bibr" rid="bib89">Shinkai et al., 1992</xref>). Duplicates were generated for each subset, with each biological replicate derived from three mice. Both males and females were used. Sorted cells were cryopreserved in 50% FBS/40% growth media/10% DMSO in aliquots of 100,000 cells, which were subjected to ATAC-seq, as follows. After membrane permeabilization, a transposase loaded with sequencing adaptors was added, which mediated insertion of adaptors at accessible genomic locations. Libraries were amplified and subjected to paired-end next-generation sequencing using the Illumina platform. Paired-end ATAC-seq libraries were generated and sequenced by Active Motif (Carlsbad, CA, USA).</p></sec><sec id="s4-13"><title>ATAC-seq analysis</title><p>Bcl2fastq2 (v2.20) was used to process Illumina base-call data and perform demultiplexing, and bwa (v0.7.12) was used to align reads to the reference genome (mm10). Samtools (v0.1.19) was used to process BAM files. BEDtools (v2.25.0) was used to process BED files, and wigToBigWig (v4) was used to generate bigWIG files. bigWIG files were aligned using the Integrative Genomics Viewer (IgV) software (v2.16.2). Each sample yielded ~65 million mapped reads.</p></sec><sec id="s4-14"><title>Gene ontology analysis</title><p>Genes differentially expressed between cluster 1 and cluster 4 with a significance of log<sub>2</sub>FC&gt;0.25 and adjusted p-value&lt;0.001 (<xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>) were submitted to ShinyGO 8.0 (<xref ref-type="bibr" rid="bib29">Ge et al., 2020</xref>) for gene ontology analysis. Pathway inclusion was set at a minimum of five genes with a false discovery rate (FDR) of 0.05. Genes were analyzed using the KEGG pathway database (<xref ref-type="bibr" rid="bib48">Kanehisa et al., 2025</xref>; <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Results were visualized as a bar graph showing fold enrichment (numbers) and –log<sub>10</sub>(FDR) values (colors).</p></sec><sec id="s4-15"><title>Alignment of ChIP-seq data</title><p>ChIP-seq data for <italic>Rag2<sup>-/-</sup></italic> DN3 and Rag DN3 + γδTCR cells binding to HEB and E2A were generated as follows: <italic>Rag2<sup>-/-</sup></italic> fetal liver hematopoietic cells were cultured on OP9-DL4 stroma to produce DN3 cells. <italic>Rag2<sup>-/-</sup></italic> DN3 cells were retrovirally transduced with the KN6 γδTCR or control (no TCR), and sorted GFP<sup>+</sup> DN3 cells were cultured for 4 days on stroma expressing the weak KN6 ligand T10 to initiate γδTCR signaling. These cells were subjected to ChIP-seq using anti-E2A and anti-HEB antibodies as previously described (<xref ref-type="bibr" rid="bib28">Fahl et al., 2021</xref>). All other files were obtained from the Cistrome database (<xref ref-type="bibr" rid="bib106">Zheng et al., 2019</xref>). Peaks were aligned to the mouse genome (mm38) using the IgV (<xref ref-type="bibr" rid="bib81">Robinson et al., 2011</xref>). Sources were as follows: Thy anti-TCRb-Egr2, GEO accession # GSM845900 (<xref ref-type="bibr" rid="bib86">Seiler et al., 2012</xref>); Rag d7 aCD3-RNA pol II, GEO accession # GSM1340642 (<xref ref-type="bibr" rid="bib77">Pekowska et al., 2011</xref>); DN3 H3K27me3, GEO accession # GSM1498423, and DN4 H3K27me3, GEO accession # GSM1498422 (<xref ref-type="bibr" rid="bib73">Oravecz et al., 2015</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Supervision, Validation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Writing – original draft, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Mice were bred and maintained in the Comparative Research Facility of the Sunnybrook Research Institute (Toronto, Ontario, Canada) under specific pathogen-free conditions. All animal procedures were approved by the Sunnybrook Research Institute Animal Care Committee under animal user protocol (AUP) 22204 and in compliance with the Canadian Council of Animal Care guidelines.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-109197-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Matrix files and R-markdown code for the HEB and Id3 scRNA-seq have been deposited to the Dryad repository and can be accessed within the &quot;Single cell RNA-seq data of E18 fetal thymocytes from HEB Vav-iCre and Id3-KO mice and their wild type littermate counterparts&quot; dataset: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.08kprr5cq">https://doi.org/10.5061/dryad.08kprr5cq</ext-link>. ATAC-seq bigwig files can be accessed within the Dryad repository in the &quot;ATAC-seq data from DN3 and DN4 cells from WT, HEBcKO, and Rag2-KO mice&quot; dataset: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.4tmpg4fr5">https://doi.org/10.5061/dryad.4tmpg4fr5</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Selvaratnam</surname><given-names>JS</given-names></name><name><surname>Dutra Barbosa da Rocha</surname><given-names>J</given-names></name><name><surname>Rajan</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Reddy</surname><given-names>EC</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Gams</surname><given-names>M</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Wiest</surname><given-names>D</given-names></name><name><surname>Guidos</surname><given-names>CJ</given-names></name><name><surname>Zuniga-Pflucker</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Data from: Single cell RNA-seq data of E18 fetal thymocytes from HEB Vav-iCre and Id3-KO mice and their wild type littermate counterparts</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.08kprr5cq</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Selvaratnam</surname><given-names>JS</given-names></name><name><surname>da Rocha</surname><given-names>JD</given-names></name><name><surname>Rajan</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Reddy</surname><given-names>EC</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Gams</surname><given-names>MS</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Wiest</surname><given-names>D</given-names></name><name><surname>Guidos</surname><given-names>CJ</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2026">2026</year><data-title>ATAC-seq data from DN3 and DN4 cells from WT, HEBcKO, and Rag2-KO mice</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.4tmpg4fr5</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Contreras</surname><given-names>AV</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Harly</surname><given-names>C</given-names></name><name><surname>Radtke</surname><given-names>F</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Sen</surname><given-names>JM</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Chip-Seq analysis on developing gamma-delta T cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM162290">GSM162290</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>MP</given-names></name><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Liszewski</surname><given-names>MK</given-names></name><name><surname>Spooner</surname><given-names>CJ</given-names></name><name><surname>Barr</surname><given-names>K</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Anti-TCRb_inj</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM845900">GSM845900</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Pekowska</surname><given-names>A</given-names></name><name><surname>Benoukraf</surname><given-names>T</given-names></name><name><surname>Zacarias-Cabeza</surname><given-names>J</given-names></name><name><surname>Belhocine</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>F</given-names></name><name><surname>Holota</surname><given-names>H</given-names></name><name><surname>Imbert</surname><given-names>J</given-names></name><name><surname>Andrau</surname><given-names>JC</given-names></name><name><surname>Ferrier</surname><given-names>P</given-names></name><name><surname>Spicuglia</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>PolII N20 RagCD3</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM1340642">GSM1340642</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Oravecz</surname><given-names>A</given-names></name><name><surname>Apostolov</surname><given-names>A</given-names></name><name><surname>Polak</surname><given-names>K</given-names></name><name><surname>Jost</surname><given-names>B</given-names></name><name><surname>Le Gras</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Kastner</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>WT_DN3_H3K27me3_exp2</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM1498422">GSM1498422</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Lisa Wells, Madeline Harvey, Vivien Musiime, and the SRI Animal Facility for excellent mouse care. We thank Yuan Zhuang (Duke University) for provision of the HEB cKO mice. We are indebted to the SickKids Flow Cytometry Core (supported by the Canadian Foundation for Innovation and the SickKids’ Foundation) for antibody panel design and high-parameter flow cytometry analysis, and the SRI Flow Cytometry and Microscopy Core for flow cytometry and sorting. We also thank the UHN Princess Margaret Genomics Facility for construction of the WT and HEB cKO scRNA-seq libraries. The Digital Research Alliance of Canada (RRG #5070) provided cloud computing capacity for scRNA-seq data analysis.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonzo</surname><given-names>ES</given-names></name><name><surname>Gottschalk</surname><given-names>RA</given-names></name><name><surname>Das</surname><given-names>J</given-names></name><name><surname>Egawa</surname><given-names>T</given-names></name><name><surname>Hobbs</surname><given-names>RM</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><name><surname>Pereira</surname><given-names>P</given-names></name><name><surname>Nichols</surname><given-names>KE</given-names></name><name><surname>Koretzky</surname><given-names>GA</given-names></name><name><surname>Jordan</surname><given-names>MS</given-names></name><name><surname>Sant’Angelo</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3</article-title><source>Journal of Immunology</source><volume>184</volume><fpage>1268</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903218</pub-id><pub-id pub-id-type="pmid">20038637</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves de Lima</surname><given-names>K</given-names></name><name><surname>Rustenhoven</surname><given-names>J</given-names></name><name><surname>Da Mesquita</surname><given-names>S</given-names></name><name><surname>Wall</surname><given-names>M</given-names></name><name><surname>Salvador</surname><given-names>AF</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Martelossi Cebinelli</surname><given-names>G</given-names></name><name><surname>Mamuladze</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>W</given-names></name><name><surname>Papadopoulos</surname><given-names>Z</given-names></name><name><surname>Lopes</surname><given-names>MB</given-names></name><name><surname>Cao</surname><given-names>WS</given-names></name><name><surname>Xie</surname><given-names>XS</given-names></name><name><surname>Herz</surname><given-names>J</given-names></name><name><surname>Kipnis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons</article-title><source>Nature Immunology</source><volume>21</volume><fpage>1421</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0776-4</pub-id><pub-id pub-id-type="pmid">32929273</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>MK</given-names></name><name><surname>Weiss</surname><given-names>AH</given-names></name><name><surname>Hernandez-Hoyos</surname><given-names>G</given-names></name><name><surname>Dionne</surname><given-names>CJ</given-names></name><name><surname>Rothenberg</surname><given-names>EV</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage</article-title><source>Immunity</source><volume>16</volume><fpage>285</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(02)00277-7</pub-id><pub-id pub-id-type="pmid">11869688</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Shifting gears: Id3 enables recruitment of E proteins to new targets during T cell development and differentiation</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>956156</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.956156</pub-id><pub-id pub-id-type="pmid">35983064</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>G</given-names></name><name><surname>Romanow</surname><given-names>WJ</given-names></name><name><surname>Albers</surname><given-names>K</given-names></name><name><surname>Havran</surname><given-names>WL</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Positive and negative regulation of V(D)J recombination by the E2A proteins</article-title><source>The Journal of Experimental Medicine</source><volume>189</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1084/jem.189.2.289</pub-id><pub-id pub-id-type="pmid">9892611</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bain</surname><given-names>G</given-names></name><name><surname>Cravatt</surname><given-names>CB</given-names></name><name><surname>Loomans</surname><given-names>C</given-names></name><name><surname>Alberola-Ila</surname><given-names>J</given-names></name><name><surname>Hedrick</surname><given-names>SM</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade</article-title><source>Nature Immunology</source><volume>2</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1038/84273</pub-id><pub-id pub-id-type="pmid">11175815</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldarelli</surname><given-names>RM</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Ringwald</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name><name><surname>Bult</surname><given-names>CJ</given-names></name><name><surname>Mouse Genome Informatics</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Mouse genome informatics: an integrated knowledgebase system for the laboratory mouse</article-title><source>Genetics</source><volume>227</volume><elocation-id>iyae031</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyae031</pub-id><pub-id pub-id-type="pmid">38531069</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barndt</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>MF</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis</article-title><source>Journal of Immunology</source><volume>163</volume><fpage>3331</fpage><lpage>3343</lpage><pub-id pub-id-type="pmid">10477603</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barndt</surname><given-names>RJ</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>6677</fpage><lpage>6685</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.18.6677-6685.2000</pub-id><pub-id pub-id-type="pmid">10958665</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros-Martins</surname><given-names>J</given-names></name><name><surname>Schmolka</surname><given-names>N</given-names></name><name><surname>Fontinha</surname><given-names>D</given-names></name><name><surname>Pires de Miranda</surname><given-names>M</given-names></name><name><surname>Simas</surname><given-names>JP</given-names></name><name><surname>Brok</surname><given-names>I</given-names></name><name><surname>Ferreira</surname><given-names>C</given-names></name><name><surname>Veldhoen</surname><given-names>M</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name><name><surname>Serre</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Effector γδ T cell differentiation relies on master but not auxiliary th cell transcription factors</article-title><source>Journal of Immunology</source><volume>196</volume><fpage>3642</fpage><lpage>3652</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501921</pub-id><pub-id pub-id-type="pmid">26994218</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berrett</surname><given-names>H</given-names></name><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Roman</surname><given-names>O</given-names></name><name><surname>Cordova</surname><given-names>A</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>XH</given-names></name><name><surname>Alberola-Ila</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development of type 2 innate lymphoid cells is selectively inhibited by sustained E protein activity</article-title><source>ImmunoHorizons</source><volume>3</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.4049/immunohorizons.1900045</pub-id><pub-id pub-id-type="pmid">31852728</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunstein</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HEB-deficient T-cell precursors lose T-cell potential and adopt an alternative pathway of differentiation</article-title><source>Molecular and Cellular Biology</source><volume>31</volume><fpage>971</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1128/MCB.01034-10</pub-id><pub-id pub-id-type="pmid">21189289</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buus</surname><given-names>TB</given-names></name><name><surname>Geisler</surname><given-names>C</given-names></name><name><surname>Lauritsen</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The major diversification of Vgamma1.1(+) and Vgamma2(+) thymocytes in mice occurs after commitment to the gammadelta T-cell lineage</article-title><source>European Journal of Immunology</source><volume>46</volume><fpage>2363</fpage><lpage>2375</lpage><pub-id pub-id-type="doi">10.1002/eji.201646407</pub-id><pub-id pub-id-type="pmid">27418188</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buus</surname><given-names>TB</given-names></name><name><surname>Ødum</surname><given-names>N</given-names></name><name><surname>Geisler</surname><given-names>C</given-names></name><name><surname>Lauritsen</surname><given-names>JPH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Three distinct developmental pathways for adaptive and two IFN-γ-producing γδ T subsets in adult thymus</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1911</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01963-w</pub-id><pub-id pub-id-type="pmid">29203769</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carleton</surname><given-names>M</given-names></name><name><surname>Ruetsch</surname><given-names>NR</given-names></name><name><surname>Berger</surname><given-names>MA</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Kaptik</surname><given-names>S</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Signals transduced by CD3, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro</article-title><source>The Journal of Immunology</source><volume>163</volume><fpage>2576</fpage><lpage>2585</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.163.5.2576</pub-id><pub-id pub-id-type="pmid">10452996</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>ELY</given-names></name><name><surname>Lee</surname><given-names>CR</given-names></name><name><surname>Thompson</surname><given-names>PK</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ontogenic timing, T cell receptor signal strength, and Notch signaling direct γδ T cell functional differentiation in vivo</article-title><source>Cell Reports</source><volume>35</volume><elocation-id>109227</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109227</pub-id><pub-id pub-id-type="pmid">34107257</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciofani</surname><given-names>M</given-names></name><name><surname>Zuniga-Pflucker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Determining gammadelta versus alphass T cell development</article-title><source>Nature Reviews</source><volume>10</volume><fpage>657</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1038/nri2820</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>S-Y</given-names></name><name><surname>Buus</surname><given-names>TB</given-names></name><name><surname>Lauritsen</surname><given-names>J-PH</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Joachims</surname><given-names>ML</given-names></name><name><surname>Thompson</surname><given-names>LF</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>329</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1084/jem.20131540</pub-id><pub-id pub-id-type="pmid">24493796</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Cruz</surname><given-names>LM</given-names></name><name><surname>Lind</surname><given-names>KC</given-names></name><name><surname>Wu</surname><given-names>BB</given-names></name><name><surname>Fujimoto</surname><given-names>JK</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Loss of E protein transcription factors E2A and HEB delays memory-precursor formation during the CD8+ T-cell immune response</article-title><source>European Journal of Immunology</source><volume>42</volume><fpage>2031</fpage><lpage>2041</lpage><pub-id pub-id-type="doi">10.1002/eji.201242497</pub-id><pub-id pub-id-type="pmid">22585759</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Skavdis</surname><given-names>G</given-names></name><name><surname>Harker</surname><given-names>N</given-names></name><name><surname>Coles</surname><given-names>M</given-names></name><name><surname>Tolaini</surname><given-names>M</given-names></name><name><surname>Norton</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Roderick</surname><given-names>K</given-names></name><name><surname>Potocnik</surname><given-names>AJ</given-names></name><name><surname>Kioussis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transgenic mice with hematopoietic and lymphoid specific expression of Cre</article-title><source>European Journal of Immunology</source><volume>33</volume><fpage>314</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/immu.200310005</pub-id><pub-id pub-id-type="pmid">12548562</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>EC</given-names></name><name><surname>Girardi</surname><given-names>M</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Hayday</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Alpha beta and gamma delta T cells can share a late common precursor</article-title><source>Current Biology</source><volume>5</volume><fpage>659</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(95)00131-x</pub-id><pub-id pub-id-type="pmid">7552177</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>du Halgouet</surname><given-names>A</given-names></name><name><surname>Bruder</surname><given-names>K</given-names></name><name><surname>Peltokangas</surname><given-names>N</given-names></name><name><surname>Darbois</surname><given-names>A</given-names></name><name><surname>Obwegs</surname><given-names>D</given-names></name><name><surname>Salou</surname><given-names>M</given-names></name><name><surname>Thimme</surname><given-names>R</given-names></name><name><surname>Hofmann</surname><given-names>M</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Multimodal profiling reveals site-specific adaptation and tissue residency hallmarks of γδ T cells across organs in mice</article-title><source>Nature Immunology</source><volume>25</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1038/s41590-023-01710-y</pub-id><pub-id pub-id-type="pmid">38177282</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Love</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>New insights into TCR β-selection</article-title><source>Trends in Immunology</source><volume>42</volume><fpage>735</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/j.it.2021.06.005</pub-id><pub-id pub-id-type="pmid">34261578</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmanuel</surname><given-names>AO</given-names></name><name><surname>Arnovitz</surname><given-names>S</given-names></name><name><surname>Haghi</surname><given-names>L</given-names></name><name><surname>Mathur</surname><given-names>PS</given-names></name><name><surname>Mondal</surname><given-names>S</given-names></name><name><surname>Quandt</surname><given-names>J</given-names></name><name><surname>Okoreeh</surname><given-names>MK</given-names></name><name><surname>Maienschein-Cline</surname><given-names>M</given-names></name><name><surname>Khazaie</surname><given-names>K</given-names></name><name><surname>Dose</surname><given-names>M</given-names></name><name><surname>Gounari</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes</article-title><source>Nature Immunology</source><volume>19</volume><fpage>1366</fpage><lpage>1378</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0254-4</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>I</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>E2A proteins enforce a proliferation checkpoint in developing thymocytes</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>202</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600017</pub-id><pub-id pub-id-type="pmid">14685278</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Coffey</surname><given-names>F</given-names></name><name><surname>Kain</surname><given-names>L</given-names></name><name><surname>Zarin</surname><given-names>P</given-names></name><name><surname>Dunbrack</surname><given-names>RL</given-names><suffix>Jr</suffix></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Role of a selecting ligand in shaping the murine γδ-TCR repertoire</article-title><source>PNAS</source><volume>115</volume><fpage>1889</fpage><lpage>1894</lpage><pub-id pub-id-type="doi">10.1073/pnas.1718328115</pub-id><pub-id pub-id-type="pmid">29432160</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2018">2018b</year><chapter-title>TCR signaling circuits in alphabeta/gammadelta t lineage choice</chapter-title><person-group person-group-type="editor"><name><surname>Soboloff</surname><given-names>J</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name></person-group><source>Signaling Mechanisms Regulating T Cell Diversity and Function</source><publisher-name>CRC Press/Taylor &amp; Francis</publisher-name><fpage>85</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1201/9781315371689-6</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Contreras</surname><given-names>AV</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Harly</surname><given-names>C</given-names></name><name><surname>Radtke</surname><given-names>F</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Xue</surname><given-names>H-H</given-names></name><name><surname>Sen</surname><given-names>JM</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The E protein-TCF1 axis controls γδ T cell development and effector fate</article-title><source>Cell Reports</source><volume>34</volume><elocation-id>108716</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.108716</pub-id><pub-id pub-id-type="pmid">33535043</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>SX</given-names></name><name><surname>Jung</surname><given-names>D</given-names></name><name><surname>Yao</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title><source>Bioinformatics</source><volume>36</volume><fpage>2628</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz931</pub-id><pub-id pub-id-type="pmid">31882993</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>EE</given-names></name><name><surname>Ramírez-Valle</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Karjalainen</surname><given-names>KE</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Deficiency in IL-17-committed Vγ4(+) γδ T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis</article-title><source>Nature Immunology</source><volume>14</volume><fpage>584</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/ni.2585</pub-id><pub-id pub-id-type="pmid">23624556</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigoriadou</surname><given-names>K</given-names></name><name><surname>Boucontet</surname><given-names>L</given-names></name><name><surname>Pereira</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Most IL-4-producing gamma delta thymocytes of adult mice originate from fetal precursors</article-title><source>Journal of Immunology</source><volume>171</volume><fpage>2413</fpage><lpage>2420</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.5.2413</pub-id><pub-id pub-id-type="pmid">12928388</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>W</given-names></name><name><surname>Pereira</surname><given-names>P</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Gamma/delta cells</article-title><source>Annual Review of Immunology</source><volume>11</volume><fpage>637</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1146/annurev.iy.11.040193.003225</pub-id><pub-id pub-id-type="pmid">8476575</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>JD</given-names></name><name><surname>Ravens</surname><given-names>S</given-names></name><name><surname>Düber</surname><given-names>S</given-names></name><name><surname>Sandrock</surname><given-names>I</given-names></name><name><surname>Oberdörfer</surname><given-names>L</given-names></name><name><surname>Kashani</surname><given-names>E</given-names></name><name><surname>Chennupati</surname><given-names>V</given-names></name><name><surname>Föhse</surname><given-names>L</given-names></name><name><surname>Naumann</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>Förster</surname><given-names>R</given-names></name><name><surname>Prinz</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Development of interleukin-17-producing γδ T cells is restricted to a functional embryonic wave</article-title><source>Immunity</source><volume>37</volume><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.06.003</pub-id><pub-id pub-id-type="pmid">22770884</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Lefebvre</surname><given-names>JM</given-names></name><name><surname>Lauritsen</surname><given-names>JPH</given-names></name><name><surname>Carleton</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Attenuation of gammadeltaTCR signaling efficiently diverts thymocytes to the alphabeta lineage</article-title><source>Immunity</source><volume>22</volume><fpage>595</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.04.003</pub-id><pub-id pub-id-type="pmid">15894277</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Pokrovskii</surname><given-names>M</given-names></name><name><surname>Kroehling</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>B-R</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element</article-title><source>Immunity</source><volume>55</volume><fpage>2027</fpage><lpage>2043</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2022.09.013</pub-id><pub-id pub-id-type="pmid">36243007</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>B</given-names></name><name><surname>Krangel</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Long-distance regulation of fetal V(δ) gene segment TRDV4 by the Tcrd enhancer</article-title><source>Journal of Immunology</source><volume>187</volume><fpage>2484</fpage><lpage>2491</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100468</pub-id><pub-id pub-id-type="pmid">21784972</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names><suffix>III</suffix></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havran</surname><given-names>WL</given-names></name><name><surname>Allison</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors</article-title><source>Nature</source><volume>344</volume><fpage>68</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/344068a0</pub-id><pub-id pub-id-type="pmid">1968230</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilig</surname><given-names>JS</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Diversity of murine gamma genes and expression in fetal and adult T lymphocytes</article-title><source>Nature</source><volume>322</volume><fpage>836</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/322836a0</pub-id><pub-id pub-id-type="pmid">2943999</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heng</surname><given-names>TSP</given-names></name><name><surname>Painter</surname><given-names>MW</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2008">2008</year><article-title>The Immunological Genome Project: networks of gene expression in immune cells</article-title><source>Nature Immunology</source><volume>9</volume><fpage>1091</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1038/ni1008-1091</pub-id><pub-id pub-id-type="pmid">18800157</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikawa</surname><given-names>T</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Goldrath</surname><given-names>AW</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment</article-title><source>The Journal of Experimental Medicine</source><volume>203</volume><fpage>1329</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1084/jem.20060268</pub-id><pub-id pub-id-type="pmid">16682500</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>In</surname><given-names>TSH</given-names></name><name><surname>Trotman-Grant</surname><given-names>A</given-names></name><name><surname>Fahl</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>ELY</given-names></name><name><surname>Zarin</surname><given-names>P</given-names></name><name><surname>Moore</surname><given-names>AJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HEB is required for the specification of fetal IL-17-producing γδ T cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>2004</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02225-5</pub-id><pub-id pub-id-type="pmid">29222418</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inácio</surname><given-names>D</given-names></name><name><surname>Amado</surname><given-names>T</given-names></name><name><surname>Pamplona</surname><given-names>A</given-names></name><name><surname>Sobral</surname><given-names>D</given-names></name><name><surname>Cunha</surname><given-names>C</given-names></name><name><surname>Santos</surname><given-names>RF</given-names></name><name><surname>Oliveira</surname><given-names>L</given-names></name><name><surname>Rouquié</surname><given-names>N</given-names></name><name><surname>Carmo</surname><given-names>AM</given-names></name><name><surname>Lesourne</surname><given-names>R</given-names></name><name><surname>Gomes</surname><given-names>AQ</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Signature cytokine-associated transcriptome analysis of effector γδ T cells identifies subset-specific regulators of peripheral activation</article-title><source>Nature Immunology</source><volume>26</volume><fpage>497</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/s41590-024-02073-8</pub-id><pub-id pub-id-type="pmid">39881001</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>ME</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors</article-title><source>Immunity</source><volume>27</volume><fpage>860</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.10.014</pub-id><pub-id pub-id-type="pmid">18093538</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>ME</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development</article-title><source>Immunologic Research</source><volume>49</volume><fpage>202</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/s12026-010-8182-x</pub-id><pub-id pub-id-type="pmid">21128008</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones-Mason</surname><given-names>ME</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Kappes</surname><given-names>D</given-names></name><name><surname>Lasorella</surname><given-names>A</given-names></name><name><surname>Iavarone</surname><given-names>A</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>E protein transcription factors are required for the development of CD4(+) lineage T cells</article-title><source>Immunity</source><volume>36</volume><fpage>348</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.02.010</pub-id><pub-id pub-id-type="pmid">22425249</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadakia</surname><given-names>T</given-names></name><name><surname>Tai</surname><given-names>X</given-names></name><name><surname>Kruhlak</surname><given-names>M</given-names></name><name><surname>Wisniewski</surname><given-names>J</given-names></name><name><surname>Hwang</surname><given-names>I-Y</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Guinter</surname><given-names>TI</given-names></name><name><surname>Alag</surname><given-names>A</given-names></name><name><surname>Kehrl</surname><given-names>JH</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>E-protein-regulated expression of CXCR4 adheres preselection thymocytes to the thymic cortex</article-title><source>The Journal of Experimental Medicine</source><volume>216</volume><fpage>1749</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1084/jem.20182285</pub-id><pub-id pub-id-type="pmid">31201207</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Ishiguro-Watanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>KEGG: biological systems database as a model of the real world</article-title><source>Nucleic Acids Research</source><volume>53</volume><fpage>D672</fpage><lpage>D677</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae909</pub-id><pub-id pub-id-type="pmid">39417505</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashani</surname><given-names>E</given-names></name><name><surname>Fohse</surname><given-names>L</given-names></name><name><surname>Raha</surname><given-names>S</given-names></name><name><surname>Sandrock</surname><given-names>I</given-names></name><name><surname>Oberdorfer</surname><given-names>L</given-names></name><name><surname>Koenecke</surname><given-names>C</given-names></name><name><surname>Prinz</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A clonotypic Vgamma4Jgamma1/Vdelta5Ddelta2Jdelta1 innate gammadelta T-cell population restricted to the CCR6(+)CD27(-) subset</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>25765849</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7477</pub-id><pub-id pub-id-type="pmid">25765849</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlgruber</surname><given-names>AC</given-names></name><name><surname>Gal-Oz</surname><given-names>ST</given-names></name><name><surname>LaMarche</surname><given-names>NM</given-names></name><name><surname>Shimazaki</surname><given-names>M</given-names></name><name><surname>Duquette</surname><given-names>D</given-names></name><name><surname>Koay</surname><given-names>H-F</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Mina</surname><given-names>AI</given-names></name><name><surname>Paras</surname><given-names>T</given-names></name><name><surname>Tavakkoli</surname><given-names>A</given-names></name><name><surname>von Andrian</surname><given-names>U</given-names></name><name><surname>Uldrich</surname><given-names>AP</given-names></name><name><surname>Godfrey</surname><given-names>DI</given-names></name><name><surname>Banks</surname><given-names>AS</given-names></name><name><surname>Shay</surname><given-names>T</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name><name><surname>Lynch</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>γδ T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis</article-title><source>Nature Immunology</source><volume>19</volume><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0094-2</pub-id><pub-id pub-id-type="pmid">29670241</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreslavsky</surname><given-names>T</given-names></name><name><surname>Savage</surname><given-names>AK</given-names></name><name><surname>Hobbs</surname><given-names>R</given-names></name><name><surname>Gounari</surname><given-names>F</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Pereira</surname><given-names>P</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name><name><surname>von Boehmer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>TCR-inducible PLZF transcription factor required for innate phenotype of a subset of γδ T cells with restricted TCR diversity</article-title><source>PNAS</source><volume>106</volume><fpage>12453</fpage><lpage>12458</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903895106</pub-id><pub-id pub-id-type="pmid">19617548</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamoorthy</surname><given-names>V</given-names></name><name><surname>Carr</surname><given-names>T</given-names></name><name><surname>de Pooter</surname><given-names>RF</given-names></name><name><surname>Emanuelle</surname><given-names>AO</given-names></name><name><surname>Gounari</surname><given-names>F</given-names></name><name><surname>Kee</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway</article-title><source>Journal of Immunology</source><volume>194</volume><fpage>3191</fpage><lpage>3200</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402443</pub-id><pub-id pub-id-type="pmid">25710912</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauritsen</surname><given-names>JPH</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Lefebvre</surname><given-names>JM</given-names></name><name><surname>Ciofani</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Marked induction of the helix-loop-helix protein Id3 promotes the γδ T cell fate and renders their functional maturation notch independent</article-title><source>Immunity</source><volume>31</volume><fpage>565</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.07.010</pub-id><pub-id pub-id-type="pmid">19833086</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Stadanlick</surname><given-names>J</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice</article-title><source>Seminars in Immunology</source><volume>22</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2010.04.008</pub-id><pub-id pub-id-type="pmid">20471282</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Coffey</surname><given-names>F</given-names></name><name><surname>Fahl</surname><given-names>SP</given-names></name><name><surname>Peri</surname><given-names>S</given-names></name><name><surname>Rhodes</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>KQ</given-names></name><name><surname>Carleton</surname><given-names>M</given-names></name><name><surname>Hedrick</surname><given-names>SM</given-names></name><name><surname>Fehling</surname><given-names>HJ</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Kappes</surname><given-names>DJ</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fates</article-title><source>Immunity</source><volume>41</volume><fpage>934</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.021</pub-id><pub-id pub-id-type="pmid">25526308</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>IMGT, the international ImMunoGeneTics database</article-title><source>Nucleic Acids Research</source><volume>31</volume><fpage>307</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1093/nar/gkg085</pub-id><pub-id pub-id-type="pmid">12520009</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>JP-T</given-names></name><name><surname>Haddadi</surname><given-names>S</given-names></name><name><surname>Geuenich</surname><given-names>MJ</given-names></name><name><surname>Tuncer</surname><given-names>A</given-names></name><name><surname>Musiime</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>J-C</given-names></name><name><surname>Campbell</surname><given-names>KR</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>HEB restrains effector gene expression during early CD8<sup>+</sup> memory precursor T cell differentiation</article-title><source>Molecular and Cellular Biology</source><volume>45</volume><fpage>283</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1080/10985549.2025.2505730</pub-id><pub-id pub-id-type="pmid">40418130</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Jhunjhunwala</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Welinder</surname><given-names>E</given-names></name><name><surname>Mansson</surname><given-names>R</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Hagman</surname><given-names>J</given-names></name><name><surname>Espinoza</surname><given-names>CA</given-names></name><name><surname>Dutkowski</surname><given-names>J</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate</article-title><source>Nature Immunology</source><volume>11</volume><fpage>635</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/ni.1891</pub-id><pub-id pub-id-type="pmid">20543837</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cook</surname><given-names>C</given-names></name><name><surname>Sedgewick</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Fassett</surname><given-names>MS</given-names></name><name><surname>Ricardo-Gonzalez</surname><given-names>RR</given-names></name><name><surname>Cheng</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell profiling reveals divergent</article-title><source>Globally Patterned Immune Responses in Murine Skin Inflammation. iScience</source><volume>23</volume><elocation-id>101582</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2020.101582</pub-id><pub-id pub-id-type="pmid">41451447</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>BC</given-names></name><name><surname>Gold</surname><given-names>MJ</given-names></name><name><surname>Hughes</surname><given-names>MR</given-names></name><name><surname>Antignano</surname><given-names>F</given-names></name><name><surname>Valdez</surname><given-names>Y</given-names></name><name><surname>Zaph</surname><given-names>C</given-names></name><name><surname>Harder</surname><given-names>KW</given-names></name><name><surname>McNagny</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn’s disease</article-title><source>Science Immunology</source><volume>1</volume><elocation-id>eaaf8864</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aaf8864</pub-id><pub-id pub-id-type="pmid">28670633</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Kovalovsky</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>PLZF controls the development of fetal-derived IL-17+Vγ6+ γδ T cells</article-title><source>Journal of Immunology</source><volume>195</volume><fpage>4273</fpage><lpage>4281</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500939</pub-id><pub-id pub-id-type="pmid">26408661</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Narayan</surname><given-names>K</given-names></name><name><surname>Cho</surname><given-names>OH</given-names></name><name><surname>Sylvia</surname><given-names>KE</given-names></name><name><surname>Yin</surname><given-names>C</given-names></name><name><surname>Melichar</surname><given-names>H</given-names></name><name><surname>Rashighi</surname><given-names>M</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name><name><surname>Harris</surname><given-names>JE</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2013">2013</year><article-title>A network of high-mobility group box transcription factors programs innate interleukin-17 production</article-title><source>Immunity</source><volume>38</volume><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.01.010</pub-id><pub-id pub-id-type="pmid">23562159</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>M-L</given-names></name><name><surname>Pang</surname><given-names>DJ</given-names></name><name><surname>Haque</surname><given-names>SFY</given-names></name><name><surname>Potocnik</surname><given-names>AJ</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name><name><surname>Hayday</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells</article-title><source>PNAS</source><volume>109</volume><fpage>17549</fpage><lpage>17554</lpage><pub-id pub-id-type="doi">10.1073/pnas.1204327109</pub-id><pub-id pub-id-type="pmid">23047700</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mistri</surname><given-names>SK</given-names></name><name><surname>Hilton</surname><given-names>BM</given-names></name><name><surname>Horrigan</surname><given-names>KJ</given-names></name><name><surname>Andretta</surname><given-names>ES</given-names></name><name><surname>Savard</surname><given-names>R</given-names></name><name><surname>Dienz</surname><given-names>O</given-names></name><name><surname>Hampel</surname><given-names>KJ</given-names></name><name><surname>Gerrard</surname><given-names>DL</given-names></name><name><surname>Rose</surname><given-names>JT</given-names></name><name><surname>Sidiropoulos</surname><given-names>N</given-names></name><name><surname>Majumdar</surname><given-names>D</given-names></name><name><surname>Boyson</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>SLAM/SAP signaling regulates discrete γδ T cell developmental checkpoints and shapes the innate-like γδ TCR repertoire</article-title><source>eLife</source><volume>13</volume><elocation-id>RP97229</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.97229</pub-id><pub-id pub-id-type="pmid">39656519</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Rivera</surname><given-names>RR</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Agata</surname><given-names>Y</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells</article-title><source>Nature Immunology</source><volume>12</volume><fpage>992</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1038/ni.2086</pub-id><pub-id pub-id-type="pmid">21857655</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>AJ</given-names></name><name><surname>Saito</surname><given-names>R</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The E-Id protein axis specifies adaptive lymphoid cell identity and suppresses thymic innate lymphoid cell development</article-title><source>Immunity</source><volume>46</volume><fpage>818</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.04.022</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>K</given-names></name><name><surname>Horie</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Hidaka</surname><given-names>R</given-names></name><name><surname>Hayashi</surname><given-names>R</given-names></name><name><surname>Hayatsu</surname><given-names>N</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name><name><surname>Kuwata</surname><given-names>R</given-names></name><name><surname>Uehata</surname><given-names>T</given-names></name><name><surname>Ochi</surname><given-names>Y</given-names></name><name><surname>Takenaka</surname><given-names>M</given-names></name><name><surname>Kawaguchi</surname><given-names>RK</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Hozumi</surname><given-names>K</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name><name><surname>Kondoh</surname><given-names>G</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>A feedback amplifier circuit with Notch and E2A orchestrates T-cell fate and suppresses the innate lymphoid cell lineages during thymic ontogeny</article-title><source>Genes &amp; Development</source><volume>39</volume><fpage>384</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1101/gad.352111.124</pub-id><pub-id pub-id-type="pmid">39904558</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Ruiz</surname><given-names>M</given-names></name><name><surname>Ribot</surname><given-names>JC</given-names></name><name><surname>Grosso</surname><given-names>AR</given-names></name><name><surname>Gonçalves-Sousa</surname><given-names>N</given-names></name><name><surname>Pamplona</surname><given-names>A</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name><name><surname>Regueiro</surname><given-names>JR</given-names></name><name><surname>Fernández-Malavé</surname><given-names>E</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets</article-title><source>Nature Immunology</source><volume>17</volume><fpage>721</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1038/ni.3424</pub-id><pub-id pub-id-type="pmid">27043412</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muro</surname><given-names>R</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Okamura</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program</article-title><source>Journal of Clinical Investigation</source><volume>128</volume><fpage>415</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1172/JCI95837</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Helix–loop–helix proteins and the advent of cellular diversity: 30 years of discovery</article-title><source>Genes &amp; Development</source><volume>33</volume><fpage>6</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1101/gad.320663.118</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayan</surname><given-names>K</given-names></name><name><surname>Sylvia</surname><given-names>KE</given-names></name><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Yin</surname><given-names>CC</given-names></name><name><surname>Martens</surname><given-names>G</given-names></name><name><surname>Vallerskog</surname><given-names>T</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>N</given-names></name><name><surname>Cohen</surname><given-names>NR</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><collab>Immunological Genome Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes</article-title><source>Nature Immunology</source><volume>13</volume><fpage>511</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/ni.2247</pub-id><pub-id pub-id-type="pmid">22473038</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nozaki</surname><given-names>M</given-names></name><name><surname>Wakae</surname><given-names>K</given-names></name><name><surname>Tamaki</surname><given-names>N</given-names></name><name><surname>Sakamoto</surname><given-names>S</given-names></name><name><surname>Ohnishi</surname><given-names>K</given-names></name><name><surname>Uejima</surname><given-names>T</given-names></name><name><surname>Minato</surname><given-names>N</given-names></name><name><surname>Yanagihara</surname><given-names>I</given-names></name><name><surname>Agata</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of TCR Vγ2 gene rearrangement by the helix-loop-helix protein, E2A</article-title><source>International Immunology</source><volume>23</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxr005</pub-id><pub-id pub-id-type="pmid">21421735</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oravecz</surname><given-names>A</given-names></name><name><surname>Apostolov</surname><given-names>A</given-names></name><name><surname>Polak</surname><given-names>K</given-names></name><name><surname>Jost</surname><given-names>B</given-names></name><name><surname>Le Gras</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Kastner</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ikaros mediates gene silencing in T cells through Polycomb repressive complex 2</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8823</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9823</pub-id><pub-id pub-id-type="pmid">26549758</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankow</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>XH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The divergence between T cell and innate lymphoid cell fates controlled by E and Id proteins</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>960444</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.960444</pub-id><pub-id pub-id-type="pmid">36032069</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papotto</surname><given-names>PH</given-names></name><name><surname>Reinhardt</surname><given-names>A</given-names></name><name><surname>Prinz</surname><given-names>I</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases</article-title><source>Journal of Autoimmunity</source><volume>87</volume><fpage>26</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2017.11.006</pub-id><pub-id pub-id-type="pmid">29203226</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>ME</given-names></name><name><surname>Mehta</surname><given-names>NU</given-names></name><name><surname>Liao</surname><given-names>TC</given-names></name><name><surname>Tomaszewski</surname><given-names>WH</given-names></name><name><surname>Snyder</surname><given-names>SA</given-names></name><name><surname>Busch</surname><given-names>J</given-names></name><name><surname>Ciofani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis</article-title><source>Nature Immunology</source><volume>26</volume><fpage>1299</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/s41590-025-02206-7</pub-id><pub-id pub-id-type="pmid">40579554</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekowska</surname><given-names>A</given-names></name><name><surname>Benoukraf</surname><given-names>T</given-names></name><name><surname>Zacarias-Cabeza</surname><given-names>J</given-names></name><name><surname>Belhocine</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>F</given-names></name><name><surname>Holota</surname><given-names>H</given-names></name><name><surname>Imbert</surname><given-names>J</given-names></name><name><surname>Andrau</surname><given-names>J-C</given-names></name><name><surname>Ferrier</surname><given-names>P</given-names></name><name><surname>Spicuglia</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>H3K4 tri-methylation provides an epigenetic signature of active enhancers</article-title><source>The EMBO Journal</source><volume>30</volume><fpage>4198</fpage><lpage>4210</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.295</pub-id><pub-id pub-id-type="pmid">21847099</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokrovskii</surname><given-names>M</given-names></name><name><surname>Herman</surname><given-names>JS</given-names></name><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Sock</surname><given-names>E</given-names></name><name><surname>Zeis</surname><given-names>P</given-names></name><name><surname>Lausch</surname><given-names>U</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Tanriver</surname><given-names>Y</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name><name><surname>Grün</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Deciphering the regulatory landscape of fetal and adult γδ T-cell development at single-cell resolution</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e104159</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019104159</pub-id><pub-id pub-id-type="pmid">32627520</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Bajana</surname><given-names>S</given-names></name><name><surname>Georgescu</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>H-C</given-names></name><name><surname>Adrianto</surname><given-names>I</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Alberola-Ila</surname><given-names>J</given-names></name><name><surname>Wren</surname><given-names>JD</given-names></name><name><surname>Sun</surname><given-names>X-H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors</article-title><source>The Journal of Experimental Medicine</source><volume>216</volume><fpage>884</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1084/jem.20182100</pub-id><pub-id pub-id-type="pmid">30898894</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribot</surname><given-names>JC</given-names></name><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>γδ T cells in tissue physiology and surveillance</article-title><source>Nature Reviews. Immunology</source><volume>21</volume><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-00452-4</pub-id><pub-id pub-id-type="pmid">33057185</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandrock</surname><given-names>I</given-names></name><name><surname>Reinhardt</surname><given-names>A</given-names></name><name><surname>Ravens</surname><given-names>S</given-names></name><name><surname>Binz</surname><given-names>C</given-names></name><name><surname>Wilharm</surname><given-names>A</given-names></name><name><surname>Martins</surname><given-names>J</given-names></name><name><surname>Oberdörfer</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Naumann</surname><given-names>R</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>Förster</surname><given-names>R</given-names></name><name><surname>Prinz</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic models reveal origin, persistence and non-redundant functions of IL-17-producing γδ T cells</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>3006</fpage><lpage>3018</lpage><pub-id pub-id-type="doi">10.1084/jem.20181439</pub-id><pub-id pub-id-type="pmid">30455268</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scaramuzzino</surname><given-names>S</given-names></name><name><surname>Potier</surname><given-names>D</given-names></name><name><surname>Ordioni</surname><given-names>R</given-names></name><name><surname>Grenot</surname><given-names>P</given-names></name><name><surname>Payet-Bornet</surname><given-names>D</given-names></name><name><surname>Luche</surname><given-names>H</given-names></name><name><surname>Malissen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Single-cell transcriptomics uncovers an instructive T-cell receptor role in adult gammadelta T-cell lineage commitment</article-title><source>The EMBO Journal</source><volume>41</volume><elocation-id>e110023</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2021110023</pub-id><pub-id pub-id-type="pmid">35128689</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmolka</surname><given-names>N</given-names></name><name><surname>Serre</surname><given-names>K</given-names></name><name><surname>Grosso</surname><given-names>AR</given-names></name><name><surname>Rei</surname><given-names>M</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name><name><surname>Gomes</surname><given-names>AQ</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory gammadelta T cell subsets</article-title><source>Nature Immunology</source><volume>14</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1038/ni.2702</pub-id><pub-id pub-id-type="pmid">23995235</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Engel</surname><given-names>I</given-names></name><name><surname>Fallahi-Sichani</surname><given-names>M</given-names></name><name><surname>Petrie</surname><given-names>HT</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development</article-title><source>PNAS</source><volume>103</volume><fpage>9976</fpage><lpage>9981</lpage><pub-id pub-id-type="doi">10.1073/pnas.0603728103</pub-id><pub-id pub-id-type="pmid">16782810</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>MP</given-names></name><name><surname>Mathew</surname><given-names>R</given-names></name><name><surname>Liszewski</surname><given-names>MK</given-names></name><name><surname>Spooner</surname><given-names>CJ</given-names></name><name><surname>Barr</surname><given-names>K</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Bendelac</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling</article-title><source>Nature Immunology</source><volume>13</volume><fpage>264</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/ni.2230</pub-id><pub-id pub-id-type="pmid">22306690</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Itsumi</surname><given-names>M</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers</article-title><source>Journal of Immunology</source><volume>181</volume><fpage>5940</fpage><lpage>5947</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.9.5940</pub-id><pub-id pub-id-type="pmid">18941182</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>SB</given-names></name><name><surname>Lo</surname><given-names>BC</given-names></name><name><surname>Ghaedi</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Messing</surname><given-names>M</given-names></name><name><surname>Hernaez</surname><given-names>DC</given-names></name><name><surname>Cait</surname><given-names>J</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Hughes</surname><given-names>MR</given-names></name><name><surname>Leslie</surname><given-names>KB</given-names></name><name><surname>Underhill</surname><given-names>TM</given-names></name><name><surname>Takei</surname><given-names>F</given-names></name><name><surname>McNagny</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursors</article-title><source>Blood Advances</source><volume>4</volume><fpage>5362</fpage><lpage>5372</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2020002758</pub-id><pub-id pub-id-type="pmid">33137203</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinkai</surname><given-names>Y</given-names></name><name><surname>Rathbun</surname><given-names>G</given-names></name><name><surname>Lam</surname><given-names>KP</given-names></name><name><surname>Oltz</surname><given-names>EM</given-names></name><name><surname>Stewart</surname><given-names>V</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Charron</surname><given-names>J</given-names></name><name><surname>Datta</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>F</given-names></name><name><surname>Stall</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement</article-title><source>Cell</source><volume>68</volume><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90029-c</pub-id><pub-id pub-id-type="pmid">1547487</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegemund</surname><given-names>S</given-names></name><name><surname>Shepherd</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Sauer</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0124661</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0124661</pub-id><pub-id pub-id-type="pmid">25884630</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spidale</surname><given-names>NA</given-names></name><name><surname>Sylvia</surname><given-names>K</given-names></name><name><surname>Narayan</surname><given-names>K</given-names></name><name><surname>Miu</surname><given-names>B</given-names></name><name><surname>Frascoli</surname><given-names>M</given-names></name><name><surname>Melichar</surname><given-names>HJ</given-names></name><name><surname>Zhihao</surname><given-names>W</given-names></name><name><surname>Kisielow</surname><given-names>J</given-names></name><name><surname>Palin</surname><given-names>A</given-names></name><name><surname>Serwold</surname><given-names>T</given-names></name><name><surname>Love</surname><given-names>P</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Yoshimoto</surname><given-names>M</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interleukin-17-producing γδ T cells originate from SOX13+ progenitors that are independent of γδTCR signaling</article-title><source>Immunity</source><volume>49</volume><fpage>857</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.09.010</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumaria</surname><given-names>N</given-names></name><name><surname>Grandjean</surname><given-names>CL</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name><name><surname>Pennington</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Strong TCRγδ signaling prohibits thymic development of IL-17A-secreting γδ T cells</article-title><source>Cell Reports</source><volume>19</volume><fpage>2469</fpage><lpage>2476</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.071</pub-id><pub-id pub-id-type="pmid">28636936</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turchinovich</surname><given-names>G</given-names></name><name><surname>Hayday</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells</article-title><source>Immunity</source><volume>35</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.04.018</pub-id><pub-id pub-id-type="pmid">21737317</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Claus</surname><given-names>CL</given-names></name><name><surname>Vaccarelli</surname><given-names>G</given-names></name><name><surname>Braunstein</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>TM</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Rothenberg</surname><given-names>EV</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors</article-title><source>Journal of Immunology</source><volume>177</volume><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.1.109</pub-id><pub-id pub-id-type="pmid">16785505</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Claus</surname><given-names>CL</given-names></name><name><surname>Rajkumar</surname><given-names>P</given-names></name><name><surname>Braunstein</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>AJ</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Context-dependent regulation of hematopoietic lineage choice by HEBAlt</article-title><source>Journal of Immunology</source><volume>185</volume><fpage>4109</fpage><lpage>4117</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901783</pub-id><pub-id pub-id-type="pmid">20826759</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welinder</surname><given-names>E</given-names></name><name><surname>Mansson</surname><given-names>R</given-names></name><name><surname>Mercer</surname><given-names>EM</given-names></name><name><surname>Bryder</surname><given-names>D</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The transcription factors E2A and HEB act in concert to induce the expression of FOXO1 in the common lymphoid progenitor</article-title><source>PNAS</source><volume>108</volume><fpage>17402</fpage><lpage>17407</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111766108</pub-id><pub-id pub-id-type="pmid">21972416</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojciechowski</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>A</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression</article-title><source>Journal of Immunology</source><volume>178</volume><fpage>5717</fpage><lpage>5726</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.9.5717</pub-id><pub-id pub-id-type="pmid">17442955</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>H</given-names></name><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Engel</surname><given-names>I</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Kersh</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Interplay between RORgammat, Egr3, and E proteins controls proliferation in response to pre-TCR signals</article-title><source>Immunity</source><volume>24</volume><fpage>813</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.03.023</pub-id><pub-id pub-id-type="pmid">16782036</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Barros-Martins</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wencker</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Smout</surname><given-names>J</given-names></name><name><surname>Ravens</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>RORgammat(+) c-Maf(+) Vgamma4(+) gammadelta T cells are generated in the adult thymus but do not reach the periphery</article-title><source>Cell Reports</source><volume>42</volume><elocation-id>113230</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.113230</pub-id><pub-id pub-id-type="pmid">37815917</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoganathan</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>A</given-names></name><name><surname>Rocha</surname><given-names>J</given-names></name><name><surname>Trotman-Grant</surname><given-names>A</given-names></name><name><surname>Mohtashami</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>L</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Regulation of the signal-dependent E protein HEBAlt through a YYY motif is required for progression through t cell development</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>848577</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.848577</pub-id><pub-id pub-id-type="pmid">35990644</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarin</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Mohtashami</surname><given-names>M</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Enforcement of γδ-lineage commitment by the pre-T-cell receptor in precursors with weak γδ-TCR signals</article-title><source>PNAS</source><volume>111</volume><fpage>5658</fpage><lpage>5663</lpage><pub-id pub-id-type="doi">10.1073/pnas.1312872111</pub-id><pub-id pub-id-type="pmid">24706811</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarin</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>ELY</given-names></name><name><surname>In</surname><given-names>TSH</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gamma delta T-cell differentiation and effector function programming, TCR signal strength, when and how much?</article-title><source>Cellular Immunology</source><volume>296</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2015.03.007</pub-id><pub-id pub-id-type="pmid">25866401</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarin</surname><given-names>P</given-names></name><name><surname>In</surname><given-names>TS</given-names></name><name><surname>Chen</surname><given-names>EL</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Mohtashami</surname><given-names>M</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name><name><surname>Anderson</surname><given-names>MK</given-names></name><name><surname>Zúñiga-Pflücker</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integration of T-cell receptor, Notch and cytokine signals programs mouse γδ T-cell effector differentiation</article-title><source>Immunology and Cell Biology</source><volume>96</volume><fpage>994</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1111/imcb.12164</pub-id><pub-id pub-id-type="pmid">29754419</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>YY</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Id3 and Id2 act as a dual safety mechanism in regulating the development and population size of innate-like γδ T cells</article-title><source>Journal of Immunology</source><volume>192</volume><fpage>1055</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302694</pub-id><pub-id pub-id-type="pmid">24379125</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Belgrader</surname><given-names>P</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Bent</surname><given-names>ZW</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Ziraldo</surname><given-names>SB</given-names></name><name><surname>Wheeler</surname><given-names>TD</given-names></name><name><surname>McDermott</surname><given-names>GP</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Gregory</surname><given-names>MT</given-names></name><name><surname>Shuga</surname><given-names>J</given-names></name><name><surname>Montesclaros</surname><given-names>L</given-names></name><name><surname>Underwood</surname><given-names>JG</given-names></name><name><surname>Masquelier</surname><given-names>DA</given-names></name><name><surname>Nishimura</surname><given-names>SY</given-names></name><name><surname>Schnall-Levin</surname><given-names>M</given-names></name><name><surname>Wyatt</surname><given-names>PW</given-names></name><name><surname>Hindson</surname><given-names>CM</given-names></name><name><surname>Bharadwaj</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Ness</surname><given-names>KD</given-names></name><name><surname>Beppu</surname><given-names>LW</given-names></name><name><surname>Deeg</surname><given-names>HJ</given-names></name><name><surname>McFarland</surname><given-names>C</given-names></name><name><surname>Loeb</surname><given-names>KR</given-names></name><name><surname>Valente</surname><given-names>WJ</given-names></name><name><surname>Ericson</surname><given-names>NG</given-names></name><name><surname>Stevens</surname><given-names>EA</given-names></name><name><surname>Radich</surname><given-names>JP</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Hindson</surname><given-names>BJ</given-names></name><name><surname>Bielas</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively parallel digital transcriptional profiling of single cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14049</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id><pub-id pub-id-type="pmid">28091601</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Mei</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>C-H</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cistrome data browser: expanded datasets and new tools for gene regulatory analysis</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D729</fpage><lpage>D735</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1094</pub-id><pub-id pub-id-type="pmid">30462313</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Barndt</surname><given-names>RJ</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Kelley</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Functional replacement of the mouse E2A gene with a human HEB cDNA</article-title><source>Molecular and Cellular Biology</source><volume>18</volume><fpage>3340</fpage><lpage>3349</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.6.3340</pub-id><pub-id pub-id-type="pmid">9584174</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuberbuehler</surname><given-names>MK</given-names></name><name><surname>Parker</surname><given-names>ME</given-names></name><name><surname>Wheaton</surname><given-names>JD</given-names></name><name><surname>Espinosa</surname><given-names>JR</given-names></name><name><surname>Salzler</surname><given-names>HR</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Ciofani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells</article-title><source>Nature Immunology</source><volume>20</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0274-0</pub-id><pub-id pub-id-type="pmid">30538336</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.109197.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sarin</surname><given-names>Apurva</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Institute for Stem Cell Science and Regenerative Medicine</institution><country>India</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>The study provides <bold>important</bold> mechanistic insight into the transcriptional control of γδT17 development, elegantly demonstrating how HEB and Id3 act sequentially and cooperatively to regulate γδT17 cell specification and maturation. The study provides <bold>compelling</bold> evidence that advances the understanding of E-Id protein dynamics in thymic T cell specification. The work is comprehensive, technically rigorous, and conceptually clear, and will be of interest to immunologists, developmental biologists, and those studying the molecular underpinnings of physiological outcomes.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.109197.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors use Flow cytometry and scRNA seq to identify and characterize the defect in gdT17 cell development from HEB f/f, Vav-icre (HEB cKO) and Id3 germline-deficient mice. HEB cKO mice showed defects in the gdT17 program at an early stage, and failed to properly upregulate expression of Id3 along with other genes downstream of TCR signaling. Id3KO mice showed a later defect in maturation. The results together indicate HEB and Id3 act sequentially during gdT17 development. The authors further showed that HEB and TCR signaling synergize to upregulate Id3 expression in the Scid-adh DN3-like T cell line. Analysis of previously published Chip-seq data revealed binding of HEB (and Egr2) at overlapping regulatory regions near Id3 in DN3 cells.The study provides insight into mechanisms by which HEB and Id3 act to mediate gdT17 specification and maturation. The work is well performed and clearly presented.</p><p>Comments on revisions:</p><p>The authors have answered all of my questions. I am strongly supportive of the revised work.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.109197.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript by Selvaratnam et al. defines how the transcription factor HEB integrates with TCR signaling to regulate Id3 expression in the context of gdT17 maturation in the fetal thymus. Using conditional HEB ablation driven by Vav Cre, flow cytometry, scRNA-seq, and reanalysis of ChIP-seq data the authors, provide evidence for a sequential model in which HEB and TCR-induced Egr2 cooperatively upregulate Id3, enabling gdT17 maturation and limiting diversion to the ab lineages. The work provides an important mechanistic insight into how the E/ID-protein axis coordinates gd T cell specification and effector maturation.</p><p>Strengths include:</p><p>(1) The proposed model that HEB primes, TCR induces, and Id3 stabilizes gdT17 cells in embryonal development is elegant and consistent with the findings.</p><p>(2) The choice of animal models and the study of a precise developmental window.</p><p>(3) The cross-validation of flow, scRNA-seq, and ChIP-seq reanalyses strengthens the conclusions.</p><p>(4) The study clarifies the dual role of Id3, first as an HEB-dependent maturation factor for gdT17 cells, and as a suppressor of diversion to the ab lineages.</p><p>Comments on revisions:</p><p>In this revised version of their manuscript the authors have effectively addressed all of my previous concerns. In its current form the study represents a significant advancement in our understanding of how the transcription factor HEB integrates with TCR signaling to regulate Id3 expression in the context of gdT17 maturation in the fetal thymus. In this revised version of their manuscript the authors have effectively addressed all of my previous concerns. In its current form the study represents a significant advancement in our understanding of how the transcription factor HEB integrates with TCR signaling to regulate Id3 expression in the context of gdT17 maturation in the fetal thymus.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.109197.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors of this manuscript have addressed a key concept in T cell development: how early thymus gd T cells subsets are specified and the elements that govern gd T17 versus other gd T cell subset or ab T cell subsets are specified. They show that the transcriptional regulator HEB/Tcf12 plays a critical role in specifying the gd T17 lineage and, intriguingly that it up regulates the inhibitor Id3 which is later required for further gd T17 maturation.</p><p>Strengths:</p><p>The conclusions drawn by the authors are amply supported by a detailed analysis of various stages of T cell maturation in WT and KO mouse strains at the single cell level both phenotypically, by flow cytometry for various diagnostic surface markers, and transcriptionally, by single cell sequencing. Their conclusions are balanced and well supported by the data and citations of previous literature.</p><p>Weaknesses:</p><p>I actually found this work to be quite comprehensive.</p><p>Comments on revisions:</p><p>Nothing to add here. The authors were very thorough in their original submission, and all minor issues identified have been addressed to my satisfaction.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.109197.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Selvaratnam</surname><given-names>Johanna S</given-names></name><role specific-use="author">Author</role><aff><institution>Sunnybrook Research Institute</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>da Rocha</surname><given-names>Juliana DB</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Rajan</surname><given-names>Vinothkumar</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Helen</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Reddy</surname><given-names>Emily C</given-names></name><role specific-use="author">Author</role><aff><institution>Hospital for Sick Children, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Gams</surname><given-names>Miki S</given-names></name><role specific-use="author">Author</role><aff><institution>Hospital for Sick Children, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jenny Jiahuan</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Murre</surname><given-names>Cornelis</given-names></name><role specific-use="author">Author</role><aff><institution>University of California, San Diego</institution><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wiest</surname><given-names>David</given-names></name><role specific-use="author">Author</role><aff><institution>Fox Chaser Cancer Center</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Guidos</surname><given-names>Cynthia J</given-names></name><role specific-use="author">Author</role><aff><institution>Hospital for Sick Children, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Zúñiga-Pflücker</surname><given-names>Juan Carlos</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Michele Kay</given-names></name><role specific-use="author">Author</role><aff><institution>University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>We thank the reviewers for their enthusiasm and insightful suggestions. Our responses to specific concerns and questions are detailed below.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews</bold>:</p><p><bold>Reviewer #1 (Public review):</bold></p><p>The authors use Flow cytometry and scRNA seq to identify and characterize the defect in gdT17 cell development from HEB f/f, Vav-icre (HEB cKO), and Id3 germline-deficient mice. HEB cKO mice showed defects in the gdT17 program at an early stage, and failed to properly upregulate expression of Id3 along with other genes downstream of TCR signaling. Id3KO mice showed a later defect in maturation. The results together indicate HEB and Id3 act sequentially during gdT17 development. The authors further showed that HEB and TCR signaling synergize to upregulate Id3 expression in the Scid-adh DN3-like T cell line. Analysis of previously published Chi-seq data revealed binding of HEB (and Egr2) at overlapping regulatory regions near Id3 in DN3 cells.</p><p>The study provides insight into mechanisms by which HEB and Id3 act to mediate gdT17 specification and maturation. The work is well performed and clearly presented. We only have minor comments.</p><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>The manuscript by Selvaratnam et al. defines how the transcription factor HEB integrates with TCR signaling to regulate Id3 expression in the context of gdT17 maturation in the fetal thymus. Using conditional HEB ablation driven by Vav Cre, flow cytometry, scRNA-seq, and reanalysis of ChIP-seq data the authors, provide evidence for a sequential model in which HEB and TCR-induced Egr2 cooperatively upregulate Id3, enabling gdT17 maturation and limiting diversion to the ab lineages. The work provides an important mechanistic insight into how the E/ID-protein axis coordinates gd T cell specification and effector maturation.</p><p>Strengths include:</p><p>(1) The proposed model that HEB primes, TCR induces, and Id3 stabilizes gdT17 cells in embryonal development is elegant and consistent with the findings.</p><p>(2) The choice of animal models and the study of a precise developmental window.</p><p>(3) The cross-validation of flow, scRNA-seq, and ChIP-seq reanalyses strengthens the conclusions.</p><p>(4) The study clarifies the dual role of Id3, first as an HEB-dependent maturation factor for gdT17 cells, and as a suppressor of diversion to the ab lineages.</p><p>Weaknesses:</p><p>(1) The ChIP-seq reanalysis indicates overlapping HEB, E2A, and Egr2 peaks ~60 kb upstream of Id3. Given that the Egr2 data are not generated using the same thymocyte subsets, some form of validation should be considered for the co-binding of HEB and Egr2, potentially ChIP-qPCR in sorted gdT17 progenitors.</p></disp-quote><p>We agree that this is a valid concern and continue to work on confirming the mechanism from several other angles. Validating HEB/E2A and Egr2 co-binding in gdT17 cell progenitors by ChIP-qPCR would/will be a very precise and definitive experiment, but it will be very challenging to perform, in part due to the low numbers of gdT17 precursors in the fetal thymus (note the y-axis scales in Fig. 1F, J). As a complementary approach, we have analyzed additional ChIP-seq data for HEB/E2A binding in Rag2<sup>-/-</sup> DN3 cells retrovirally transduced with the KN6 gdTCR cultured with stroma expressing the weak KN6 ligand T10 for 4 days. This analysis revealed that the binding of HEB/E2A on those sites persisted after weak gdTCR signaling, strengthening the likelihood that concurrent binding of HEB/E2A and Egr2 occurs during this developmental transition. We noted that HEB/E2A binding was slightly dampened in Rag2<sup>-/-</sup> DN3 + gdTCR cells relative to Rag2<sup>-/-</sup> DN3 cells, consistent with the induction of Id3 and subsequent Id3-mediated disruption of E protein binding. We also located HEB/E2A and Egr binding sites in close proximity in the two regions that shared peaks between HEB/E2A and Egr2 analyses (HE1 and HE2), in line with the potential participation of these two transcription factors in an enhanceosome binding complex.</p><p>Furthermore, we examined the chromatin landscape of the Id3 locus by sorting WT DN3 and DN4 cells, as well as Rag2<sup>-/-</sup> DN3 cells to provide a genuine pre-selection context, and performing ATAC-seq (Figure 7–suppl 7A). Given the known ability of E2A and HEB to induce chromatin remodeling, we also examined accessibility in DN3 and DN4 cells from HEB cKO mice. Alignment of ATAC-seq and ChIP-seq peaks in the Id3 locus revealed accessibility of HE1 and HE2 in Rag2<sup>-/-</sup>, WT DN3, and WT DN4 cells. However, accessibility of HE1 and HE2 was dampened in HEB cKO cells, especially at the DN3 stage, suggesting that HEB may be involved in remodeling the Id3 locus, resulting in a poised state that enables TCR-dependent transcription factors to induce Id3 proportionally to TCR signal strength. These data are now presented as a new “Figure 7 – figure supplement 1” with corresponding Results, Discussion, and Methods updates.</p><p>Our next story will be focused on a finer dissection of the Id3 cis-regulatory elements and their combinatorial regulation by HEB/E2A and other transcription factors, and how they relate to specific signaling pathways. For this study, we will modify the language regarding Egr2 to reflect the open questions that still remain to be addressed.</p><disp-quote content-type="editor-comment"><p>(2) E2A expression is not affected in HEB-deficient cells, raising the question of partial compensation, a point that should be specifically discussed.</p></disp-quote><p>This confounding factor is always an issue with E proteins. We have now added a section to the discussion that highlights previous literature and relates it to our findings.</p><disp-quote content-type="editor-comment"><p>(3) All experiments are done at E18, when fetal gdT17 development predominates. The discussion could address whether these mechanisms extend to neonatal or adult gdT17 subsets.</p></disp-quote><p>In our 2017 paper (PMID 29222418) we showed that HEB cKO mice have defects in the production of functional gdT17 cells in fetal and neonatal thymus and in the adult periphery (in lungs and spleen). While the adult thymus does not support the development of fully functional innate gd T cells, it does contain gdTCR+ cells that have activated the Sox-Maf-Rorc network (Yang 2023, PMID 37815917). It will be very interesting to assess the impact of HEB loss on these cells, and we are actively pursuing this goal. For now, we will add a paragraph to the discussion addressing what we know from previous work and what is yet to be learned.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>The authors of this manuscript have addressed a key concept in T cell development: how early thymus gd T cell subsets are specified and the elements that govern gd T17 versus other gd T cell subsets or ab T cell subsets are specified. They show that the transcriptional regulator HEB/Tcf12 plays a critical role in specifying the gd T17 lineage and, intriguingly, that it upregulates the inhibitor Id3, which is later required for further gd T17 maturation.</p><p>Strengths:</p><p>The conclusions drawn by the authors are amply supported by a detailed analysis of various stages of T cell maturation in WT and KO mouse strains at the single cell level, both phenotypically, by flow cytometry for various diagnostic surface markers, and transcriptionally, by single cell sequencing. Their conclusions are balanced and well supported by the data and citations of previous literature.</p><p>Weaknesses:</p><p>I actually found this work to be quite comprehensive. I have a few suggestions for additional analyses the authors could explore that are unrelated to the predominant conclusions of the manuscript, but I failed to find major flaws in the current work.</p><p>I note that HEB is expressed in many hematopoietic lineages from the earliest progenitors and throughout T cell development. It is also noteworthy that abortive gamma and delta TCR rearrangements have been observed in early NK cells and ILCs, suggesting that, particularly in early thymic development, specification of these lineages may have lower fidelity. It might prove interesting to see whether their single-cell sequencing or flow data reveal changes in the frequency of these other T-cell-related lineages. Is it possible that HEB is playing a role not only in the fidelity of gdT17 cell specification, but also perhaps in the separation of T cells from NK cells and ILCs or the frequency of DN1, DN2, and DN3 cells? Perhaps their single-cell sequencing data or flow analyses could examine the frequency of these cells? That minor caveat aside, I find this to be an extremely exciting body of work.</p></disp-quote><p>Excellent question, and the underlying answer is yes, loss of HEB renders the cells more open to divergence to non-T lineages, even at the DN3 stage. Although our datasets did not reveal those cells, we have examined this question previously. In our 2011 paper (Braunstein, 2011, PMID 21189289) where we identified “DN1-like” cells arising from HEB-/- DN3 cells in OP9-DL1 co-cultures. These cells responded to IL-15 and IL-7 by differentiating into cytotoxic NK-like cells. We did not detect TCRb rearrangements but did not look for gdTCR rearrangements. Subsequently, multiple papers from other labs showed that ILC2 were greatly expanded in the thymus using Id-overexpression transgenic mice and HEB/E2A-double deficient mice (Miyazaki, 2023, PMID 28514688; Miyazaki, 2025, PMID 39904558; Berrett, 2019, PMID 31852728; Qian, 2019, PMID 30898894; Peng, 2020, PMID:32817168). The ILCs in these mice had TCRg rearrangements, consistent with a shared origin with WT thymic-derived ILCs. In unpublished data from our lab, we found an increase in the numbers of ILC2 but not ILC3 in HEB cKO fetal thymic organ cultures. We did not follow up on this work any further since the topic was being heavily pursued in other labs, but remain very interested in this branchpoint, and will mention the literature in the discussion.</p><disp-quote content-type="editor-comment"><p><bold>Joint recommendations for the authors:</bold></p><p>(1) Experimental validation (for mechanistic clarity)</p><p>The ChIP-seq reanalysis indicates overlapping HEB, E2A, and Egr2 peaks ~60 kb upstream of Id3. Given that the Egr2 data are not generated using the same thymocyte subsets, some form of validation should be considered for the co-binding of HEB and Egr2, potentially ChIP-qPCR in sorted gdT17 progenitors to substantiate the proposed cooperative mechanism.</p></disp-quote><p>See above; new experiments with ATAC-seq and additional ChIP-seq analysis.</p><disp-quote content-type="editor-comment"><p>(2) Figures</p><p>Potential inconsistencies in Figure 1H: In the legend to Figure 1H, Vg1-Vg5- cells are considered Vg6+ cells. Flow plots show reduced A Vg1-Vg5- population in HEBc ko mice, but the accompanying bar plot shows increased frequency of Vg6+ cells.</p></disp-quote><p>Vg6 cells are actually considered to be Vg4-Vg5-Vg1- cells (not Vg4- Vg1- cells, which is important in the fetal context). The flow plot shows the percentage of Vg6 cells out of the Vg1-Vg4- population, whereas the bar plot shows the percentage of Vg6 cells out of all gdTCR+ cells. The ratio of Vg6 to Vg5 cells decreases within the Vg1-Vg4- population, whereas the overall percentages and numbers of Vg6 cells in all gd T cells is increased in HEB cKO mice. We have now more clearly explained this in the text and the figure legend.</p><disp-quote content-type="editor-comment"><p>Clarify which cells produce IL-17A in Figure 1L.</p></disp-quote><p>This plot is gated on all gd T cells stimulated with PMA/ionomycin; this has been added to the results and figure legend.</p><disp-quote content-type="editor-comment"><p>In Supplementary Figure 2, legend, do the authors mean that TRGV4 was depleted? The authors write TRDV4. Please check.</p></disp-quote><p>Thank you for catching this mistake, we have corrected it.</p><disp-quote content-type="editor-comment"><p>In Figure 7, the Author showed Id3 mRNA expression. Can the expression of Id2 be included?</p></disp-quote><p>That is a really interesting question, and we will follow up on it in future studies.</p><disp-quote content-type="editor-comment"><p>If Id1 or Id4 are relevant for any of these studies, can their expression be shown in Supplementary Figure 3A? If these are minimally expressed or not expressed, this could be mentioned.</p></disp-quote><p>Id1 and Id4 were not detectable in our studies, this is now stated in the results section describing expression of E proteins and Id proteins.</p><disp-quote content-type="editor-comment"><p>(3) Discussion</p><p>Discuss possible redundancy between HEB and E2A, as E2A expression appears unaffected in HEB-deficient cells.</p></disp-quote><p>See above</p><disp-quote content-type="editor-comment"><p>Address whether the mechanisms identified at E18 (embryonic stage) also apply to neonatal or adult γδT17 subsets.</p></disp-quote><p>See above</p><disp-quote content-type="editor-comment"><p>Expand on how HEB function may relate to other hematopoietic or early lymphoid lineages (NK/ILC, DN1-DN3 stages), based on reviewer curiosity.</p></disp-quote><p>See above</p><disp-quote content-type="editor-comment"><p>(4) Methods and terminology</p><p>Define the terms γδTe1 and γδTe2 (e.g., early effector subsets).</p></disp-quote><p>This has been defined more clearly in several sections of the text.</p><disp-quote content-type="editor-comment"><p>Add details to the scRNA-seq methods section (average number of cells analyzed and sequencing depth per cell).</p></disp-quote><p>These details have been added.</p></body></sub-article></article>